Processing 00000000.tx.1: Lithium Chloride Increases the Production of Amyloid- Peptide Independently from Its Inhibition of Glycogen Synthase Kinase 3* Christine Feyt, Pascal Kienlen-Campard, Karelle Leroy, Francisca N'Kuli, Pierre J. 

Phrase: "Lithium Chloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Production of Amyloid- Peptide Independently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "from Its Inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of Glycogen Synthase Kinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "* Christine Feyt,"

Phrase: "Pascal Kienlen-Campard,"

Phrase: "Karelle Leroy,"

Phrase: "Francisca N'Kuli,"

Phrase: "Pierre J."
Processing 00000000.tx.2: Courtoy, Jean-Pierre Brion, and Jean-Nol Octave1 From the Laboratory of Experimental Pharmacology and Cell Unit, Universit catholique de Louvain, 1200 Brussels, Belgium, Laboratory of Histology, Neuroanatomy and Neuropathology, Universit libre de Bruxelles, 1070 Brussels, Belgium Received for publication, February 11, 2005 , and in revised form, July 6, 2005.  

Phrase: "Courtoy,"

Phrase: "Jean-Pierre Brion,"

Phrase: "and"

Phrase: "Jean-Nol Octave1 From the Laboratory of Experimental Pharmacology"

Phrase: "and"

Phrase: "Cell Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Universit catholique de Louvain,"

Phrase: "1200 Brussels,"

Phrase: "Belgium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "Laboratory of Histology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022877:Laboratory [Manufactured Object,Organization]
   790   C3244292:laboratory [Functional Concept]

Phrase: "Neuroanatomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027816:Neuroanatomy [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Neuropathology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0876934:Neuropathology [Biomedical Occupation or Discipline]
  1000   C1540677:neuropathology [Pathologic Function]
  1000   C1555824:Neuropathology [Intellectual Product]

Phrase: "Universit libre de Bruxelles,"

Phrase: "1070 Brussels,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "February 11,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "July 6,"

Phrase: "2005."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Glycogen synthase kinase 3 (GSK3) is able to phosphorylate tau at many sites that are found to be phosphorylated in paired helical filaments in Alzheimer disease. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glycogen synthase kinase 3 (GSK3)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "phosphorylate"

Phrase: "tau at many sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "that"

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated in paired helical filaments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   828   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   760   C1709450:Paired [Qualitative Concept]
   726   C0010851:Filament [Cell Component]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.4: Lithium chloride (LiCl) efficiently inhibits GSK3 and was recently reported to also decrease the production of amyloid- peptide (A) from its precursor, the amyloid precursor protein. 

Phrase: "Lithium chloride (LiCl) efficiently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   827   C0008203:Chloride, NOS [Inorganic Chemical]
   827   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the production of amyloid- peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "(A) from its precursor,"

Phrase: "the amyloid precursor protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.5: Therefore, lithium has been proposed as a combined therapeutic agent, inhibiting both the hyperphosphorylation of tau and the production of A. 

Phrase: "Therefore,"

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "proposed as a combined therapeutic agent,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0304231:Therapeutic agent [Intellectual Product]
   790   C1611640:Therapeutic agent [Pharmacologic Substance]
   753   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   753   C0205195:Combined [Qualitative Concept]
   753   C0302350:Therapeutic [Functional Concept]
   753   C0450442:Agent [Chemical Viewed Functionally]
   753   C1254351:Agent [Pharmacologic Substance]
   753   C1441414:PROPOSED [Idea or Concept]
   753   C1521826:Agent [Intellectual Product]
   753   C1553874:Proposed [Qualitative Concept]
   753   C1578820:Proposed [Idea or Concept]
   719 E C0336789:Combine [Manufactured Object]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "both the hyperphosphorylation of tau"

Phrase: "and"

Phrase: "the production of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]
Processing 00000000.tx.6: Here, we demonstrate that the inhibition of GSK3 by LiCl induced the nuclear translocation of -catenin in Chinese hamster ovary cells and rat cultured neurons, in which a decrease in tau phosphorylation was observed. 

Phrase: "Here,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the inhibition of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin in Chinese hamster ovary cells"

Phrase: "and"

Phrase: "rat cultured neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in which"

Phrase: "a decrease in tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.7: In both cellular models, a nontoxic concentration of LiCl increased the production of A by increasing the -cleavage of amyloid precursor protein, generating more substrate for an unmodified -secretase activity. 

Phrase: "In both cellular models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "a nontoxic concentration of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the production of A by increasing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "the -cleavage of amyloid precursor protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "generating"

Phrase: "more substrate for an unmodified -secretase activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.8: SB415286, another GSK3 inhibitor, induced the nuclear translocation of -catenin and slightly decreased A production. 

Phrase: "SB415286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "another GSK3 inhibitor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin"

Phrase: "and"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.9: It is concluded that the LiCl-mediated increase in A production is not related to GSK3 inhibition.  

Phrase: "It"

Phrase: "is"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the LiCl-mediated increase in A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to GSK3 inhibition."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
   714 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Alzheimer disease, the most frequent cause of dementia, is characterized by the presence of typical microscopic lesions in the brain of affected patients. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the most frequent cause of dementia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "characterized by the presence of typical microscopic lesions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0205288:Microscopic [Qualitative Concept]
   744   C0221198:lesions [Finding]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1880022:Characterized [Activity]
   744   C3538928:Typical [Qualitative Concept]
   711 E C1546698:Lesion [Intellectual Product]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of affected patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522476:affected patients [Qualitative Concept]
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.11: The coexistence of intraneuronal neurofibrillary tangles and extracellular senile plaques allows confirmation of the clinical diagnosis of the disease (1). 

Phrase: "The coexistence of intraneuronal neurofibrillary tangles"

Phrase: "and"

Phrase: "extracellular senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "confirmation of the clinical diagnosis of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   744   C0750484:Confirmation [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Neurofibrillary tangles are made of paired helical filaments (PHFs)2 containing the microtubule-associated protein, tau (24). 

Phrase: "Neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "made of paired helical filaments (PHFs)2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   753   C1709450:Paired [Qualitative Concept]
   719   C0010851:Filament [Cell Component]
   719   C1881534:Make [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the microtubule-associated protein,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.13: In Alzheimer disease, tau is hyperphosphorylated, and many serine and threonine residues (5, 6) that are found to be phosphorylated in PHF tau can be phosphorylated by GSK3 in both in vitro and transfected cells (79). 

Phrase: "In Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "hyperphosphorylated"

Phrase: ","

Phrase: "and"

Phrase: "many serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "threonine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated in PHF tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   770   C0597162:PHF [Cell or Molecular Dysfunction]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated by GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.14: Senile plaques contain an amyloid core that is mainly constituted of amyloid- peptide (A) (10), which is derived from the amyloid precursor protein (APP) (11, 12). 

Phrase: "Senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an amyloid core"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "that"

Phrase: "is"

Phrase: "mainly"

Phrase: "constituted of amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) (10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "derived from the amyloid precursor protein (APP)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1441547:Derived [Qualitative Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.15: The APP gene encodes 10 different APP isoforms (13) with an amino acid content varying from 365 to 770 amino acids. 

Phrase: "The APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "10 different APP isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "(13"

Phrase: ")"

Phrase: "with an amino acid content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "varying from 365"

Phrase: "to 770 amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.16: The neuronal APP is a single pass type I transmembrane protein containing 695 amino acids (11) that is processed by amyloidogenic and nonamyloidogenic catabolic pathways. 

Phrase: "The neuronal APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a single pass type I transmembrane protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2329187:Single-pass transmembrane protein [Amino Acid, Peptide, or Protein]
   839   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1167322:transmembrane [Cell Component]
   799   C2752508:transmembrane [Cell Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "695 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "(11"

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "processed by amyloidogenic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "nonamyloidogenic catabolic pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.17: The -cleavage of APP, catalyzed by the well characterized aspartyl protease -site APP-cleaving enzyme 1 (BACE1) (14), produces a C-terminal fragment of APP (CTF), which is further cleaved by -secretase to generate A. 

Phrase: "The -cleavage of APP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "catalyzed by the well characterized aspartyl protease -site APP-"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0078989:aspartyl protease [Amino Acid, Peptide, or Protein,Enzyme]
   756   C2717969:Aspartyl Protease [Amino Acid, Peptide, or Protein,Enzyme]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205145:Site [Spatial Concept]
   738   C0205170:Well [Qualitative Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1515974:Site [Body Location or Region]
   738   C1709634:Precursor [Idea or Concept]
   738   C1880022:Characterized [Activity]
   738   C1947941:Protease [Enzyme]
   738   C2825164:Site [Spatial Concept]
   738   C3146287:Well [Manufactured Object]

Phrase: "cleaving"

Phrase: "enzyme 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(BACE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]

Phrase: ")"

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "produces"

Phrase: "a C-terminal fragment of APP (CTF),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "cleaved by -secretase to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "generate"

Phrase: "A."
Processing 00000000.tx.18: The -secretase activity is found as a multiprotein complex containing at least four different proteins: Aph-1, nicastrin, presenilin, and Pen-2 (15, 16). 

Phrase: "The -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "found as a multiprotein complex"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   726 E C0243095:Find [Finding]

Phrase: "containing at least four different proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205450:Four [Quantitative Concept]
   753   C0332256:Containing [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C2700400:Containing [Activity]

Phrase: ":"

Phrase: "Aph-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "nicastrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "presenilin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "Pen-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.19: APP can also be cleaved within the A sequence by an -secretase. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "cleaved within the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]

Phrase: "A sequence by an -secretase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.20: The -cleavage of APP generates a soluble N-terminal fragment (sAPP) and a 83-membrane-anchored C-terminal fragment (C83). 

Phrase: "The -cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "generates"

Phrase: "a soluble N-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(sAPP)"

Phrase: "and"

Phrase: "a 83-membrane-anchored C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "(C83"

Phrase: ")."
Processing 00000000.tx.21: Experimental evidence indicates that the -cleavage of APP695 could be performed by members of the desintegrin and metalloprotease family, ADAM10 and ADAM17 (17). 

Phrase: "Experimental evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the -cleavage of APP695"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "could"

Phrase: "be"

Phrase: "performed by members of the desintegrin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0680022:members [Population Group]
   753   C0884358:Performed [Functional Concept]
   719 E C2698041:Member [Professional or Occupational Group]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "metalloprotease family,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ADAM17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0529196:ADAM-17 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412186:ADAM17 [Gene or Genome]
  1000   C1706640:ADAM 17 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.22: The short intracellular C-terminal domain of APP can be phosphorylated in vitro and in vivo by several protein kinases such as cdk5, c-Jun N-terminal kinase, and GSK3 (1820). 

Phrase: "The short intracellular C-terminal domain of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo by several protein kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "such as cdk5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "c-Jun N-terminal kinase,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1820"

Phrase: ")."
Processing 00000000.tx.23: Another substrate of GSK3 is -catenin, an essential protein of the Wnt signaling pathway. 

Phrase: "Another substrate of GSK3 is -catenin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1710236:Substrate [Manufactured Object]

Phrase: "an essential protein of the Wnt signaling pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.24: In the absence of a Wnt ligand, GSK3 activity is not inhibited, resulting in the phosphorylation of soluble -catenin for ubiquitin-proteasome-mediated degradation (21). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a Wnt ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "GSK3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: ","

Phrase: "resulting in the phosphorylation of soluble -catenin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332294:Resulting in [Functional Concept]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0678226:resulting [Functional Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1749467:soluble [Cell Component]
   748   C1948047:Soluble [Qualitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "for ubiquitin-proteasome-mediated degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.25: Alternatively, as a result of GSK3 inactivation by Wnt signaling, intracellular levels of -catenin increase, allowing its binding to components of the high mobility group family of transcription factors and its translocation into the nucleus. 

Phrase: "Alternatively,"

Phrase: "as"

Phrase: "a result of GSK3 inactivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "by Wnt signaling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2984359:Wnt signaling [Functional Concept]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "intracellular levels of -catenin increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442805:Increase [Functional Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "its binding to components of the high mobility group family of transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   747   C1149367:transcription factor binding [Genetic Function]
   735   C0243122:binding [Functional Concept]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "its translocation into the nucleus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]
Processing 00000000.tx.26: LiCl, an inhibitor of GSK3 (22), reduces the phosphorylation of tau in rat cultured neurons (2325). 

Phrase: "LiCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "an inhibitor of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   774   C3537023:kinase inhibitor [Molecular Function]
   774   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "reduces"

Phrase: "the phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in rat cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(2325"

Phrase: ")."
Processing 00000000.tx.27: Interestingly, LiCl was recently reported to decrease A production in both transfected cells and transgenic mice (2629). 

Phrase: "Interestingly,"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A production in both transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(2629"

Phrase: ")."
Processing 00000000.tx.28: Therefore, lithium could be a combined therapeutic agent, inhibiting both the phosphorylation of tau and the production of A. 

Phrase: "Therefore,"

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "a combined therapeutic agent,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0304231:Therapeutic agent [Intellectual Product]
   901   C1611640:Therapeutic agent [Pharmacologic Substance]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "both the phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "the production of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]
Processing 00000000.tx.29: In this study, transfected CHO cells and rat cultured neurons expressing human APP695 and producing human A were treated with LiCl. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "rat cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "and"

Phrase: "producing human A"

Phrase: "were"

Phrase: "treated with LiCl."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.30: This GSK3 inhibitor decreased the phosphorylation of tau in neurons and induced the nuclear translocation of -catenin in both CHO cells and neurons. 

Phrase: "This GSK3 inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin in both CHO cells"

Phrase: "and"

Phrase: "neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.31: It was found that LiCl increased the -secretase activity and consequently increased the amount of CTF generated from human APP695. 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "consequently"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "generated from human APP695."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.32: The cleavage of CTF by an unchanged -secretase activity led to an overproduction of A. 

Phrase: "The cleavage of CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "by an unchanged -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "led to an overproduction of A."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   753   C1708698:LED [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.33: SB415286, another GSK3 inhibitor, induced the nuclear translocation of -catenin and slightly decreased neuronal A production. 

Phrase: "SB415286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "another GSK3 inhibitor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin"

Phrase: "and"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.34: Taken together, these results clearly demonstrate that LiCl stimulates the amyloidogenic pathway of human APP independently of its inhibition of GSK3.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "stimulates"

Phrase: "the amyloidogenic pathway of human APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: "independently of its inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Materials and AntibodiesFetal calf serum, cell culture media, and NuPageTM 412% bis-Tris gels were purchased from Invitrogen. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "AntibodiesFetal calf serum,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "cell culture media,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0007634:Cell [Cell]
   827   C0009458:Media [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0162867:Media [Tissue]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1254021:Media [Tissue]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "NuPageTM 412% bis-Tris gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "purchased from Invitrogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.36: Protein A-Sepharose CL-4B was from Amersham Biosciences. 

Phrase: "Protein A-Sepharose CL-4B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0074345:Sepharose CL 4B [Carbohydrate]
   853   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   804   C0450375:4b [Intellectual Product]
   717   C0075172:protein A-sepharose [Carbohydrate]

Phrase: "was from Amersham Biosciences."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.37: Protease inhibitors were from Roche Applied Science. 

Phrase: "Protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were from Roche Applied Science."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0681834:Applied Science [Research Activity]
   760   C0036397:Science [Occupation or Discipline]
   760   C0185125:Applied [Health Care Activity]
   760   C0331965:Roche [Health Care Related Organization]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.38: MTT reagent was obtained from Sigma. 

Phrase: "MTT reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "obtained from Sigma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.39: DAPT, a functional -secretase inhibitor (30) was a kind gift from L. 

Phrase: "DAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "a functional -secretase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: "was"

Phrase: "a kind gift from L."
Processing 00000000.tx.40: Mercken (Aventis, Vitry-sur-seine, France). 

Phrase: "Mercken"

Phrase: "(Aventis,"

Phrase: "Vitry-sur-seine,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.41: LiCl was obtained from Merck (Darmstadt, Germany). 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "obtained from Merck"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Darmstadt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.42: SB415286, an ATP-competitive inhibitor of GSK3, was kindly provided by A. 

Phrase: "SB415286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "an ATP-competitive inhibitor of GSK3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   762   C3537023:kinase inhibitor [Molecular Function]
   762   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.43: Goffinet (Universit catholique de Louvain, Brussels, Belgium). 

Phrase: "Goffinet"

Phrase: "(Universit catholique de Louvain,"

Phrase: "Brussels,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.44: The mouse WO-2 monoclonal antibody raised against amino acids 58 of human A was purchased from the Genetics Company. 

Phrase: "The mouse WO-2 monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "raised against amino acids 58 of human A"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0086418:Human [Human]
   744   C0442818:Raised [Quantitative Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "purchased from the Genetics Company."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
   760   C0683757:Company [Manufactured Object,Organization]
   760   C0869011:purchased [Activity]
Processing 00000000.tx.45: Rabbit polyclonal anti-actin serum was purchased from Sigma. 

Phrase: "Rabbit polyclonal anti-actin serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0229671:Serum [Body Substance]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.46: B19 rabbit polyclonal serum recognized tau in a phosphorylation independent-manner (31). 

Phrase: "B19 rabbit polyclonal serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "recognized"

Phrase: "tau in a phosphorylation independent-manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.47: Mouse monoclonal PHF1 antibody specifically recognizing tau phosphorylated at Ser396/Ser404 was kindly provided by P. 

Phrase: "Mouse monoclonal PHF1 antibody specifically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   853   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "phosphorylated at Ser396/Ser404"

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.48: Davies and S. 

Phrase: "Davies"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.49: Greenberg. 

Phrase: "Greenberg."
Processing 00000000.tx.50: Mouse monoclonal -catenin antibody was purchased from Transduction Laboratories (Lexington, KY). 

Phrase: "Mouse monoclonal -catenin antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   875   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Transduction Laboratories"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1160185:transduction [Organism Function]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Lexington,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.51: The polyclonal antibody anti-p58 was a kind gift from J. 

Phrase: "The polyclonal antibody anti-p58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3541311:P58 [Gene or Genome]

Phrase: "was"

Phrase: "a kind gift from J."
Processing 00000000.tx.52: Saraste (University of Bergen, Norway). 

Phrase: "Saraste"

Phrase: "(University of Bergen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Norway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028423:Norway [Geographic Area]

Phrase: ")."
Processing 00000000.tx.53: The rabbit polyclonal antibodies directed against BACE1 were from Oncogene Research (La Jolla, CA). 

Phrase: "The rabbit polyclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against BACE1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1412727:BACE1 [Gene or Genome]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "were from Oncogene Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0029016:Oncogene [Gene or Genome]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]

Phrase: "(La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)."
Processing 00000000.tx.54: Secondary antibodies were from Amersham Biosciences. 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Amersham Biosciences."
Processing 00000000.tx.55: Cell CulturesTransfected CHO cell lines expressing human APP695 were cultured as described previously (32). 

Phrase: "Cell CulturesTransfected CHO cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   897   C0007600:Cell lines [Cell]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.56: Cells were seeded at a density of 3.6 x 104 cells/cm2 in 6-, 12-, or 96-well culture dishes 24 h prior to treatment. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at a density of 3.6 x 104 cells/cm2"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   738   C0007634:Cells [Cell]
   738   C0178587:density [Quantitative Concept]
   738   C0439479:cm2 [Quantitative Concept]
   738   C0555206:CM2 [Congenital Abnormality]
   738   C3282337:Cells [Cell]
   737   C0162339:Cell Density [Quantitative Concept]
   704   C0036563:Seed [Plant]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704   C1705192:Seed [Laboratory Procedure]
   704   C1882540:{Seed} [Quantitative Concept]
   704 E C1948049:Cell [Spatial Concept]
   704   C2346495:Seed [Conceptual Entity]

Phrase: "in 6-,"

Phrase: "12-,"

Phrase: "or"

Phrase: "96-well culture dishes 24 h prior to treatment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.57: Primary cultures of cortical neurons were prepared from 17-day-old Wistar rat embryos as described previously (33). 

Phrase: "Primary cultures of cortical neurons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0010453:Cultures [Idea or Concept]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from 17-day-old Wistar rat embryos"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0034716:Wistar rat [Mammal]
   744   C0013935:Embryos [Embryonic Structure]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0332173:/day [Temporal Concept]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
   744   C0580836:Old [Temporal Concept]
   744   C2700262:Wistar [Mammal]
   711 E C1305370:Embryo [Embryonic Structure]
   711   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.58: Cells were plated in 6-, 12-, or 96-well culture dishes (4 x 105 cells/cm2) on glass coverslips (1.2 x 105 cells/cm2) pretreated with poly-L-lysine (10 g/ml in phosphate-buffered saline) and cultured for 6 days in vitro in NeurobasalTM medium supplemented with 2% B-27 and 0.5 mM L-glutamine prior to infection with recombinant adenoviruses. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in 6-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "12-,"

Phrase: "or"

Phrase: "96-well culture dishes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]
   779   C0020498:DISH [Disease or Syndrome]

Phrase: "(4 x 105 cells/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439479:cm2 [Quantitative Concept]
   804   C0555206:CM2 [Congenital Abnormality]

Phrase: ")"

Phrase: "on glass coverslips"

Phrase: "(1.2 x 105 cells/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439479:cm2 [Quantitative Concept]
   799   C0555206:CM2 [Congenital Abnormality]

Phrase: ")"

Phrase: "pretreated with poly-L-lysine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0747726:POLY [Conceptual Entity]

Phrase: "(10 g/ml in phosphate-buffered saline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cultured for 6 days in vitro"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0439228:days [Temporal Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719 E C0332173:/day [Temporal Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C0439505:/day [Temporal Concept]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "in NeurobasalTM medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 2% B-27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "0.5 mM L-glutamine prior to infection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with recombinant adenoviruses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0001483:Adenoviruses [Virus]
   861   C1514798:recombinant [Organism]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.59: Under these conditions, neuronal cultures (up to 98% of neurons) display high differentiation and survival rates (34). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "neuronal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: "up to 98%"

Phrase: "of neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "high differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "survival rates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038954:Survival Rates [Quantitative Concept]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.60: Recombinant Adenoviruses, Neuronal Infection, and Treatment The construction and purification of adenoviruses encoding human APP695 were performed as described previously (35, 36). 

Phrase: "Recombinant Adenoviruses,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0001483:Adenoviruses [Virus]
   861   C1514798:recombinant [Organism]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Neuronal Infection,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "and"

Phrase: "Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "The construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification of adenoviruses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243114:purification [Functional Concept]
   790   C1998793:Purification [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human APP695"

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.61: After 6 days in vitro, neuronal cultures were infected at a multiplicity of infection of 100 for 4 h in a minimal volume of culture medium. 

Phrase: "After 6 days in vitro,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1442469:6 Days [Temporal Concept]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: "neuronal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "infected at a multiplicity of infection of 100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0009450:Infection, NOS [Disease or Syndrome]
   744   C0439663:Infected [Functional Concept]
   744   C0449822:Multiplicity [Quantitative Concept]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in a minimal volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   964   C0231956:Minimum volume [Laboratory or Test Result]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of culture medium."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.62: Infection medium was then replaced by fresh culture medium for 4 days before treatment. 

Phrase: "Infection medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "replaced by fresh culture medium"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   806   C1299987:Replaced by [Functional Concept]
           replaced
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2827486:Fresh [Body Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "for 4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442765:4 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "before treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.63: Under these conditions, at least 75% of neurons stably express the proteins encoded by recombinant adenoviruses (33). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "at least 75%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of neurons stably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "express"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "encoded by recombinant adenoviruses"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0001483:Adenoviruses [Virus]
   770   C0679058:encoded [Mental Process]
   770   C1514798:recombinant [Organism]
   770   C2700640:Encoded [Activity]
   737 E C0001486:Adenovirus [Disease or Syndrome]
   737 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.64: Neuronal and CHO cells were treated for 24 h with 5 mM LiCl and/or 25 M SB415286 (two GSK3 inhibitors) (37) or for 8 h with 250 nM DAPT (a -secretase inhibitor) (30). 

Phrase: "Neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 5 mM LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "and/or"

Phrase: "25 M SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2713511:SB415286 [Organic Chemical]

Phrase: "(two GSK3 inhibitors"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   839   C1152564:Kinase Inhibitors [Molecular Function]
   822 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   822 E C3537023:kinase inhibitor [Molecular Function]
   822 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0243077:inhibitors [Chemical Viewed Functionally]
   766 E C1999216:Inhibitor [Qualitative Concept]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(37"

Phrase: ")"

Phrase: "or for 8 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with 250 nM DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0634829:dapt [Lipid]

Phrase: "(a -secretase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.65: Survival AssaysCells survival was measured by the colorimetric MTT assay. 

Phrase: "Survival AssaysCells survival"

Phrase: "was"

Phrase: "measured by the colorimetric MTT assay."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C2986858:MTT Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0647210:mtt [Lipid]
   753   C1510438:Assay [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.66: Cells grown in 96-well dishes were incubated for 2 h at 37 C in fresh culture medium containing 0.5 mg/ml MTT. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown in 96-well dishes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C in fresh culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Medium [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C0439536:Medium [Quantitative Concept]
   799   C1705217:Medium [Substance]
   799   C2242979:Culture [Laboratory Procedure]
   799   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5 mg/ml MTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0647210:mtt [Lipid]
Processing 00000000.tx.67: The medium was removed, and dark blue crystals that had formed were dissolved by adding 100 l/well lysis solution (isopropyl alcohol/0.04 N HCl). 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "dark blue crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0427896:Crystals [Body Substance]
   827   C0444626:Crystals [Chemical Viewed Structurally]
   827   C1378554:Crystals [Biomedical or Dental Material]
   827   C1533132:Crystals [Body Substance]
   827   C2699477:Crystals [Laboratory Procedure]
   793 E C1704641:Crystal [Manufactured Object]

Phrase: "that"

Phrase: "had"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "dissolved by adding 100 l/well lysis solution"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0024348:Lysis [Pathologic Function]
   744   C0037633:Solution [Substance]
   744   C0205170:Well [Qualitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C1536403:lysis [Cell Function]
   744   C3146287:Well [Manufactured Object]
   711   C1549535:Dissolve [Functional Concept]
   711   C1883712:Add [Functional Concept]

Phrase: "(isopropyl alcohol/0.04 N HCl"

Phrase: ")."
Processing 00000000.tx.68: Absorbance was measured at 492 nm using a microplate reader (PerkinElmer Life Sciences). 

Phrase: "Absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 492 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microplate reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.69: Protein Analysis by Western Blotting and Densitometric QuantificationCulture media and cell lysates were analyzed by Western blotting as described previously (33). 

Phrase: "Protein Analysis by Western Blotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   993   C2121086:protein analysis by Western blot [Laboratory Procedure]
   833   C0949466:Western blot analysis [Laboratory Procedure]
   806   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Densitometric QuantificationCulture media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.70: Cell lysates (10 g of protein) and culture medium (15 l) were separated in NuPageTM 412% bis-Tris gels (Invitrogen) and blotted onto nitrocellulose membranes. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(10 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "(15 l)"

Phrase: "were"

Phrase: "separated in NuPageTM 412% bis-Tris gels"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0053809:Bis-Tris [Organic Chemical]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0556985:BIS [Temporal Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C2247301:BIS [Molecular Function]
   748   C3540495:BIS [Intellectual Product]
   714 E C1382104:Gel [Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "blotted onto nitrocellulose membranes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.71: Membranes were incubated overnight at 4 C with primary antibody followed by secondary antibody coupled to horseradish peroxidase. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by secondary antibody"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "coupled to horseradish peroxidase."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]
Processing 00000000.tx.72: Immunoreactive bands were detected by ECL (Amersham Biosciences). 

Phrase: "Immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected by ECL (Amersham Biosciences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C1332684:ECL [Gene or Genome]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.73: For quantification of cellular APP, membranes were stripped and reincubated with an anti-actin antibody. 

Phrase: "For quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "of cellular APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reincubated with an anti-actin antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.74: The ratio between immunoreactive proteins and actin was quantified with an electrophoresis Gel Doc 2000 imaging system coupled to a Quantity OneTM software (Bio-Rad). 

Phrase: "The ratio between immunoreactive proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "quantified with an electrophoresis Gel Doc 2000 imaging system"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   764   C0596607:electrophoresis gel [Laboratory Procedure]
   764   C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   764   C2697665:Imaging System [Manufactured Object]
   742   C0011923:Imaging [Diagnostic Procedure]
   742   C0013855:Electrophoresis [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0079595:Imaging [Diagnostic Procedure]
   742   C0449913:System [Functional Concept]
   742   C1301746:Doc [Intellectual Product]
   742   C1382104:Gel [Substance]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   708 E C1704254:Image [Intellectual Product]
   708 E C1704922:Image [Entity]
   708   C1709793:Quantify [Quantitative Concept]
   708 E C3542466:Image [Intellectual Product]

Phrase: "coupled to a Quantity OneTM software"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0037585:Software [Intellectual Product,Manufactured Object]
   753   C1265611:Quantity [Quantitative Concept]
   753   C1554108:Quantity [Intellectual Product]
   753   C1561573:Quantity [Intellectual Product]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.75: Immunoprecipitation of CTF FragmentCTF production was monitored by immunoprecipitation of cell lysates. 

Phrase: "Immunoprecipitation of CTF FragmentCTF production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "monitored by immunoprecipitation of cell lysates."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   773   C1881488:Cell Lysate [Physical Object]
           Lysate
   753   C0007634:Cell [Cell]
   753   C0021069:Immunoprecipitation [Laboratory Procedure]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.76: Four million neurons or 0.5 million CHO cells were plated in each well of a 6-well plate. 

Phrase: "Four million neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "or"

Phrase: "0.5 million CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   853   C1881840:Million Cells [Quantitative Concept]
   840   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in each well of a 6-well plate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0205170:Well [Qualitative Concept]
   742   C3146287:Well [Manufactured Object]
   708   C0005971:Plate [Medical Device]
   708   C1139930:plate [Medical Device]
   708   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.77: Following treatment, cells were washed three times with phosphate-buffered saline and then scraped and pelleted in cold phosphate-buffered saline. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with phosphate-buffered saline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "scraped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184933:scraped [Therapeutic or Preventive Procedure]
  1000   C0444082:scraped [Body Substance]

Phrase: "and"

Phrase: "pelleted in cold phosphate-buffered saline."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C0234192:Cold [Physiologic Function]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719   C0441436:Pellet [Manufactured Object]
   719   C0993610:Pellet [Biomedical or Dental Material]
   719   C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.78: Cells were solubilized in radioimmune precipitation assay buffer containing protease inhibitors (1 g/ml pepstatin, 10 g/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride; purchased from Roche Applied Science). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "solubilized in radioimmune precipitation assay buffer containing protease inhibitors"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   764   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0032931:Precipitation [Natural Phenomenon or Process]
   742   C0032932:Precipitation [Molecular Function]
   742   C0243073:assay [Qualitative Concept]
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   742   C0332256:Containing [Functional Concept]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1642401:% precipitation [Quantitative Concept]
   742   C1947941:Protease [Enzyme]
   742   C2584299:Precipitation [Natural Phenomenon or Process]
   742   C2700400:Containing [Activity]
   731 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   708 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"

Phrase: "purchased from Roche Applied Science"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0681834:Applied Science [Research Activity]
   760   C0036397:Science [Occupation or Discipline]
   760   C0185125:Applied [Health Care Activity]
   760   C0331965:Roche [Health Care Related Organization]
   760   C0869011:purchased [Activity]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.79: The samples were precleared overnight at 4 C by incubation with 5 mg of protein A-Sepharose. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "precleared"

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "by incubation"

Phrase: "with 5 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of protein A-Sepharose."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0075172:protein A-sepharose [Carbohydrate]
   827   C0036681:Sepharose [Carbohydrate]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.80: After removal of protein A-Sepharose by centrifugation (15,800 x g for 3 min), the samples were immunoprecipitated with 1.5 g of WO-2 antibody for 12 h at 4 C. 

Phrase: "After removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of protein A-Sepharose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0075172:protein A-sepharose [Carbohydrate]
   827   C0036681:Sepharose [Carbohydrate]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "(15,800 x g for 3 min),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0118460:G-800 [Organic Chemical,Pharmacologic Substance]
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immunoprecipitated with 1.5 g of WO-2 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0439267:g% [Quantitative Concept]
   708   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "for 12 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.81: Protein A-Sepharose (5 mg) was then added overnight. 

Phrase: "Protein A-Sepharose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0075172:protein A-sepharose [Carbohydrate]
   827   C0036681:Sepharose [Carbohydrate]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(5 mg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.82: The samples were centrifuged at 15,800 x g for 3 min, and the pellets were washed three times with 1x radioimmune precipitation assay buffer (25 mM Tris, pH 7.4, 0.5% Triton X-100, 0.5% Nonidet P-40) and once with TBS buffer (10 mM Tris, pH 7.5). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 15,800 x g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0118460:G-800 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 3 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with 1x radioimmune precipitation assay buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "(25 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.5% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "0.5% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "once with TBS buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   770   C1532188:Tbsp [Quantitative Concept]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]

Phrase: "(10 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.83: Pellets were incubated for 10 min at 96 C in sample buffer (125 mM Tris, pH 6.8, 20% glycerol, 4% SDS, 10% -mercaptoethanol, 1% bromphenol blue). 

Phrase: "Pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 10 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 96 C in sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(125 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "4% SDS,"

Phrase: "10% -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "1% bromphenol blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0006247:Bromphenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C1260957:Blue [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.84: The samples were then centrifuged at 15,800 x g for 3 min, and the supernatants were loaded onto NuPageTM 412% bis-Tris gels (Invitrogen) and analyzed by Western blotting (see above). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 15,800 x g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0118460:G-800 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 3 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "loaded onto NuPageTM 412% bis-Tris gels"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0053809:Bis-Tris [Organic Chemical]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0556985:BIS [Temporal Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C1708715:Loaded [Activity]
   748   C2247301:BIS [Molecular Function]
   748   C3540495:BIS [Intellectual Product]
   714 E C1382104:Gel [Substance]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.85: Quantification of A ProductionA production was monitored by immunoprecipitation of cell culture medium. 

Phrase: "Quantification of A ProductionA production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "was"

Phrase: "monitored by immunoprecipitation of cell culture medium."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   778   C0007585:Cell Culture [Laboratory Procedure]
   778   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   748   C0007634:Cell [Cell]
   748   C0009458:Medium [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0021069:Immunoprecipitation [Laboratory Procedure]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439536:Medium [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705217:Medium [Substance]
   748   C1948049:Cell [Spatial Concept]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3244283:medium [Intellectual Product]
   714   C0030695:monitor [Health Care Activity]
   714   C0150369:monitor [Health Care Activity]
   714   C0181904:Monitor [Medical Device]
   714   C0596972:Monitor [Medical Device]
   714   C1521743:Monitor [Professional or Occupational Group]
   714   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.86: The quantification of extracellular A-(140) was performed by ELISA (BIOSOURCE, Camarillo, CA). 

Phrase: "The quantification of extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "performed by ELISA (BIOSOURCE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0014441:ELISA [Laboratory Procedure]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Camarillo,"

Phrase: "CA)."
Processing 00000000.tx.87: For both approaches, culture medium was collected, treated with protease inhibitors (1 g/ml pepstatin, 10 g/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride), and cleared by centrifugation (15,800 x g for 5 min, 4 C). 

Phrase: "For both approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "treated with protease inhibitors"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1522326:Treated [Functional Concept]
   770   C1947941:Protease [Enzyme]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cleared by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "(15,800 x g for 5 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0118460:G-800 [Organic Chemical,Pharmacologic Substance]
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]

Phrase: "4 C)."
Processing 00000000.tx.88: Supernatants (100 l) were recovered for A quantification by fluorescent sandwich ELISA assay according to the manufacturer's instructions. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "(100 l)"

Phrase: "were"

Phrase: "recovered for A quantification"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521108:recovered [Qualitative Concept]
   770   C1709793:Quantification [Quantitative Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "by fluorescent sandwich ELISA assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0014441:ELISA assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.89: Previous experiments showed that there was no cross-reaction between A-(140) and A-(142) recognition (38). 

Phrase: "Previous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "was"

Phrase: "no cross-reaction between A-(140"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0010357:Cross Reaction [Molecular Function]
   783   C0442740:No reaction [Finding]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C2828360:Cross [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "A-(142"

Phrase: ")"

Phrase: "recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.90: Fluorescence emission was measured on an HTS 7000 Plus plate reader (PerkinElmer Life Sciences) at excitation/emission wavelengths of 485 nm/535 nm, respectively. 

Phrase: "Fluorescence emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233929:Emission [Body Substance]
   861   C2349995:Emission [Substance]

Phrase: "was"

Phrase: "measured on an HTS 7000 Plus plate reader"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   744   C0005971:Plate [Medical Device]
   744   C0036085:HTS [Inorganic Chemical,Pharmacologic Substance]
   744   C0332287:Plus [Qualitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C1139930:plate [Medical Device]
   744   C1514743:Reader [Professional or Occupational Group]
   744   C1706461:Reader [Manufactured Object]
   744   C1854310:HTS [Disease or Syndrome]
   744   C3537155:Plate [Manufactured Object]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "at excitation/emission wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449819:wavelengths [Quantitative Concept]

Phrase: "of 485 nm/535 nm,"

Phrase: "respectively."
Processing 00000000.tx.91: Immunoprecipitation was performed in 1 ml of the culture medium as described previously (33). 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed in 1 ml of the culture medium"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   744   C0009458:Medium [Intellectual Product]
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1705217:Medium [Substance]
   744   C2242979:Culture [Laboratory Procedure]
   744   C3244283:medium [Intellectual Product]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.92: ImmunocytochemistryCells were fixed with 4% (w/v) paraformaldehyde in a phosphate buffer (0.1 M, pH 7.4) The immunohistochemical labeling was performed using the ABC method. 

Phrase: "ImmunocytochemistryCells"

Phrase: "were"

Phrase: "fixed with 4%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "paraformaldehyde in a phosphate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(0.1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "The immunohistochemical labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ABC method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.93: Briefly, fixed cells were treated with H2O2 to inhibit endogenous peroxidase and incubated with blocking solution (10% (v/v) normal horse serum in TBS (0.01 M Tris, 0.15 M NaCl, pH 7.4)). 

Phrase: "Briefly,"

Phrase: "fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with H2O2 to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "endogenous peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "incubated with blocking solution"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(10%"

Phrase: "(v/v) normal horse serum"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C1518416:Normal Horse Serum [Immunologic Factor]
           Serum, Horse
   865 E C0309642:NORMAL EQUINE SERUM [Organic Chemical,Pharmacologic Substance]
   804   C0019944:Horse [Mammal]
   804   C0205307:Normal [Qualitative Concept]
   804   C0229671:Serum [Body Substance]
   804   C0242616:Horse [Mammal]
   804   C0439166:% normal [Quantitative Concept]
   804   C1265527:Horse [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   804   C2347086:% Normal [Quantitative Concept]

Phrase: "in TBS (0.01 M Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   804   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   804   C0814229:TRI [Intellectual Product]

Phrase: "0.15 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.94: After overnight incubation with the diluted primary antibody, the fixed cells were sequentially incubated with horse anti-mouse antibodies conjugated to biotin (Vector, Burlingame, CA) followed by the ABC complex (Vector). 

Phrase: "After overnight incubation"

Phrase: "with the diluted primary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "sequentially"

Phrase: "incubated with horse anti-mouse antibodies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0019944:Horse [Mammal]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0242616:Horse [Mammal]
   753   C1265527:Horse [Mammal]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "conjugated to biotin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C0522529:Conjugated [Spatial Concept]
   790   C2700256:Biotin [Laboratory Procedure]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "followed by the ABC complex"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.95: Peroxidase activity was revealed using diaminobenzidine as chromogen. 

Phrase: "Peroxidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151518:peroxidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "diaminobenzidine as chromogen."
Processing 00000000.tx.96: - and -Secretase Activity AssayThe - and -secretase activities were measured by FRET-based in vitro assays. 

Phrase: "-"

Phrase: "and -"

Phrase: "Secretase Activity AssayThe -"

Phrase: "and -"

Phrase: "secretase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured by FRET-based in vitro assays."
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   780   C1515653:In Vitro Assay [Research Activity]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0597717:FRET [Laboratory Procedure]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0002055:base [Inorganic Chemical]
   714   C0005507:Assay [Laboratory Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C0242485:Measure [Functional Concept]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]
   714 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.97: CHO cells were washed, scraped in cold phosphate-buffered saline, and pelleted by centrifugation (1,000 x g for 5 min, 4 C). 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "scraped in cold phosphate-buffered saline,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C0184933:scraped [Therapeutic or Preventive Procedure]
   753   C0234192:Cold [Physiologic Function]
   753   C0444082:scraped [Body Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "pelleted by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "(1,000 x g for 5 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0560021:g/min [Quantitative Concept]
   774   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   748   C0439267:g% [Quantitative Concept]

Phrase: "4 C)."
Processing 00000000.tx.98: One hundred l of extraction buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.01% Triton X-100) was added to the cell pellet (1.5 x 106 cells). 

Phrase: "One hundred l of extraction buffer"

Phrase: "(10 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.01% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "added to the cell pellet"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1269647:Cell [Cell]
   760   C1524062:Added [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1998480:Pellet [Quantitative Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "(1.5 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.99: After brief sonication (5 s), cellular extracts were cleared by centrifugation (10,000 x g for 10 min, 4 C), and enzymatic activities were measured in the supernatant. 

Phrase: "After brief sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037680:Sonication [Research Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "s)"

Phrase: ","

Phrase: "cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "cleared by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "(10,000 x g for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]

Phrase: "4 C),"

Phrase: "and"

Phrase: "enzymatic activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured in the supernatant."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0444706:Measured [Qualitative Concept]
   770   C1550101:Supernatant [Body Substance]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.100: The -secretase assay was carried out on 20 g of proteins in reaction buffer containing the fluorogenic NH2RE(EDANS)EVNLDAEFK(DABCYL)R-OH -secretase specific substrate (39) according to the manufacturer's instructions (BioVision, Mountain View, CA). 

Phrase: "The -secretase assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on 20 g of proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   767 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]

Phrase: "in reaction buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the fluorogenic NH2RE"

Phrase: "(EDANS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048959:EDANS [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "EVNLDAEFK"

Phrase: "(DABCYL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047917:DABCYL [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "R-OH -secretase specific substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1710236:Substrate [Manufactured Object]

Phrase: "(39"

Phrase: ")"

Phrase: "according to the manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(BioVision,"

Phrase: "Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA)."
Processing 00000000.tx.101: After 1.5 h of incubation at 37 C in the dark, samples were analyzed in a HTS 7000 Plus fluorescence microplate reader with excitation/emission wavelengths of 360/535 nm, respectively. 

Phrase: "After 1.5 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0700308:1 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "of incubation"

Phrase: "at 37 C in"

Phrase: "the dark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed in a HTS 7000 Plus fluorescence microplate reader"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0182258:Microplate Reader [Medical Device]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0036085:HTS [Inorganic Chemical,Pharmacologic Substance]
   742   C0332287:Plus [Qualitative Concept]
   742   C0936012:Analyzed [Research Activity]
   742   C1514743:Reader [Professional or Occupational Group]
   742   C1706461:Reader [Manufactured Object]
   742   C1709027:Microplate [Research Device]
   742   C1854310:HTS [Disease or Syndrome]

Phrase: "with excitation/emission wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449819:wavelengths [Quantitative Concept]

Phrase: "of 360/535 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.102: Positive controls were performed with purified human -secretase (10 g/ml, final concentration). 

Phrase: "Positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "performed with purified human -secretase"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0884358:Performed [Functional Concept]
   760   C1998793:Purified [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(10 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.103: The -secretase inhibitor used in the assays was Z-VLL-CHO (40). 

Phrase: "The -secretase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "used in the assays"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1273517:used [Finding]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737   C0243073:assay [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "Z-VLL-CHO (40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1565132:Z-VLL-CHO [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.104: The -secretase activity was measured by the QTL LightspeedTM -secretase assay (QTL Biosystems, Santa Fe, NM). 

Phrase: "The -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by the QTL LightspeedTM -secretase assay"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0597336:QTL [Gene or Genome]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(QTL Biosystems,"

Phrase: "Santa Fe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "NM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0312860:NM [Cell Function]
Processing 00000000.tx.105: Approximately 10 g of cellular extract were mixed to -secretase substrate (GVVIATVK, flanked by biotin and a fluorescence quencher, 20 M) in 20 l (final volume) of assay buffer (50 mM Tris-HCl,, pH 7, 2 mM EDTA, 0.05% bovine serum albumin, 2 mM reduced glutathione). 

Phrase: "Approximately 10 g of cellular extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "to -secretase substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "(GVVIATVK,"

Phrase: "flanked by biotin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C2700256:Biotin [Laboratory Procedure]
   756   C0230171:Flank [Body Location or Region]

Phrase: "and"

Phrase: "a fluorescence quencher,"

Phrase: "20"

Phrase: "M) in 20 l (final volume"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205088:Final [Temporal Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1546485:Final [Idea or Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: ")"

Phrase: "of assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50 mM Tris-HCl,"

Phrase: ", pH 7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.05% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "2 mM reduced glutathione"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034917:Reduced Glutathione [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0392756:Reduced [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.106: After 2 h of incubation in the dark, 40 l of QTL SensorTM (41) was added, and the fluorescence was measured in a microplate reader with excitation/emission wavelengths of 430/595 nm, respectively. 

Phrase: "After 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation"

Phrase: "in the dark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "40 l of QTL SensorTM"

Phrase: "(41"

Phrase: ")"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured in a microplate reader"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0182258:Microplate Reader [Medical Device]
   760   C0444706:Measured [Qualitative Concept]
   760   C1514743:Reader [Professional or Occupational Group]
   760   C1706461:Reader [Manufactured Object]
   760   C1709027:Microplate [Research Device]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "with excitation/emission wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449819:wavelengths [Quantitative Concept]

Phrase: "of 430/595 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.107: Results are expressed as - and -secretase activities/mg of cellular protein. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed"

Phrase: "as -"

Phrase: "and -"

Phrase: "secretase activities/mg of cellular protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.108: View larger version (35K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.109: LiCl treatment increases A-(140) production in CHO cells expressing human APP695. 

Phrase: "LiCl treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A-(140"

Phrase: ")"

Phrase: "production in CHO cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "expressing"

Phrase: "human APP695."
Processing 00000000.tx.110: The expression of human APP695 and its metabolites was analyzed in transfected CHO cell lines (APP+) by Western blotting using the WO-2 antibody. 

Phrase: "The expression of human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its metabolites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870883:Metabolites [Biologically Active Substance]
  1000   C2698672:METABOLITES [Regulation or Law]

Phrase: "was"

Phrase: "analyzed in transfected CHO cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0007600:Cell lines [Cell]
   790   C0085080:CHO cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "(APP+"

Phrase: ")"

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the WO-2 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.111: A, expression of human APP695 in cell lysates (upper left). 

Phrase: "A,"

Phrase: "expression of human APP695 in cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(upper left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.112: Protein loading was controlled by incubating membranes with an anti-actin antibody (lower left). 

Phrase: "Protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "controlled by incubating membranes"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   833   C0332298:Controlled by [Functional Concept]
   770   C0025255:Membranes [Tissue]
   770   C1439852:incubating [Laboratory Procedure]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1550141:Control [Substance]
   737 E C1706182:Membrane [Manufactured Object]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "with an anti-actin antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "(lower left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.113: Expression of sAPP (upper right) and detection of extracellular A after immunoprecipitation in the culture medium (lower right) are shown. 

Phrase: "Expression of sAPP (upper right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "detection of extracellular A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "after immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "in the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "(lower right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.114: CHO cells were treated with 0, 1, 2.5, 5, 10, or 20 mM LiCl for 24 h (left) or 48 h (right). 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "or"

Phrase: "20 mM LiCl for 24 h (left"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   744   C0008203:Chloride, NOS [Inorganic Chemical]
   744   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "or"

Phrase: "48 h (right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.115: B, cell survival was measured using the MTT assay. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.116: Results (mean  S.E.) are given as the percentage of survival of untreated cells (0 mM); 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "are"

Phrase: "given as the percentage of survival of untreated cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   745   C0007620:Cell Survival [Cell Function]
   742   C0007634:Cells [Cell]
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   742   C0332155:untreated [Finding]
   742   C0439165:Percentage [Quantitative Concept]
   742   C1442162:GIVEN [Conceptual Entity]
   742   C1549488:Percentage [Idea or Concept]
   742   C1550718:given [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C3244317:given [Intellectual Product]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1947971:Give [Functional Concept]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(0 mM"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.117: n = 16; 

Phrase: "n = 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.118: ***, p < 0.001 when compared with control. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.119: C, the extracellular A-(140) was quantified by ELISA. 

Phrase: "C,"

Phrase: "the extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: ")"

Phrase: "was"

Phrase: "quantified by ELISA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.120: Results are expressed as percentage of A-(140) produced by nontreated CHO cells (0 mM); 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as percentage of A-(140"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: ")"

Phrase: "produced by nontreated CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(0 mM"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.121: n = 4; 

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.122: ***, p < 0.001 when compared with control. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.123: D, CHO cells were incubated in the presence or absence of 5 mM LiCl. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 5 mM LiCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.124: A-(140) was quantified in the culture medium by ELISA before (0 h) or after (24 h) a 24-h incubation at 37 C. 

Phrase: "A-(140"

Phrase: ")"

Phrase: "was"

Phrase: "quantified in the culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726   C1709793:Quantify [Quantitative Concept]

Phrase: "by ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "before"

Phrase: "(0 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "after"

Phrase: "(24 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "a 24-h incubation at 37 C."
Processing 00000000.tx.125: Results (mean  S.E.) are expressed as the percentage of control (0 h); 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "are"

Phrase: "expressed as the percentage of control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0243148:control [Qualitative Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1561533:Percentage [Idea or Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(0 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.126: n = 4; 

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.127: ***, p < 0.001 when compared with control (0 h). 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(0 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.128: E, anti--catenin immunolabeling of untreated CHO cells (NT, not treated) or cells treated for 24 h with 5 mM LiCl. 

Phrase: "E,"

Phrase: "anti"

Phrase: "--"

Phrase: "catenin immunolabeling of untreated CHO cells"

Phrase: "(NT,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 5 mM LiCl."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]
Processing 00000000.tx.129: Scale bars,10 m.  

Phrase: "Scale bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.130: Analytical Subcellular FractionationCells were incubated with 4 g/ml [125I]transferrin for 5 min, 37 C. 

Phrase: "Analytical Subcellular FractionationCells"

Phrase: "were"

Phrase: "incubated with 4 g/ml [125I"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "]transferrin for 5 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1442762:TRANSFERRIN [Gene or Genome]

Phrase: "37 C."
Processing 00000000.tx.131: Under these conditions, transferrin is an early endosomal marker. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "transferrin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1442762:TRANSFERRIN [Gene or Genome]
   916 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "an early endosomal marker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.132: Cells were recovered in 0.25 M sucrose containing 1 mM EDTA, 3 mM imidazole buffered at pH 7.4, and complete protease inhibitors (Roche Applied Science). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "recovered in 0.25 M sucrose"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0521108:recovered [Qualitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   719 E C2004454:recover [Organism Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "3 mM imidazole"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   827   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "buffered at pH 7.4,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1882074:pH 7 [Qualitative Concept]
   797   C2678549:PH-4 [Gene or Genome]
   781   C0492253:PH BUFFER [Medical Device]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "complete protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.133: Cellular suspension was homogenized in a tight Dounce homogenizer. 

Phrase: "Cellular suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "homogenized in a tight Dounce homogenizer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0181200:homogenizer [Medical Device]
   753   C0439816:Tight [Qualitative Concept]
   753   C0453911:tight [Manufactured Object]
Processing 00000000.tx.134: A low-speed nuclear fraction was pelleted at 1,000 x g for 10 min and washed three times by resuspension and sedimentation. 

Phrase: "A low-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678536:Speed [Quantitative Concept]

Phrase: "nuclear fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "000 x g for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0560021:g/min [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "washed three times by resuspension"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "sedimentation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597428:Sedimentation [Laboratory Procedure]
  1000   C1384604:Sedimentation [Natural Phenomenon or Process]
Processing 00000000.tx.135: Pooled postnuclear supernatants were further sedimented at 100,000 x g for 60 min in a Ti50 rotor (Beckman). 

Phrase: "Pooled postnuclear supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "sedimented at 100,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C1550099:Sediment [Body Substance]

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in a Ti50 rotor"

Phrase: "(Beckman"

Phrase: ")."
Processing 00000000.tx.136: The high-speed pellet was resuspended in 0.3 ml of homogenization buffer, mixed with 2.3 M sucrose to reach 1.28 g/ml in density, and layered at the bottom of a linear sucrose gradient (from 1.10 to 1.24 g/ml in density). 

Phrase: "The high-speed pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441436:Pellet [Manufactured Object]
   827   C0993610:Pellet [Biomedical or Dental Material]
   827   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 0.3 ml of homogenization buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "mixed with 2.3 M sucrose to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0205430:Mixed [Functional Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   748   C3160715:Mixed [Finding]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1720722:Mix [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "1.28 g/ml in density,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "layered at the bottom of a linear sucrose gradient"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0205132:Linear [Spatial Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C0934502:Layered [Body Part, Organ, or Organ Component]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1511276:Bottom [Spatial Concept]
   742   C1552825:bottom [Idea or Concept]
   708 E C1522408:Layer [Qualitative Concept]
   708 E C1561599:Layer [Intellectual Product]

Phrase: "("

Phrase: "from 1.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "to 1.24 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "in density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.137: After floatation by centrifugation at 200,000 g for 22 h in a Sw40 rotor (Beckman), 12 fractions were collected and analyzed for protein content. 

Phrase: "After floatation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678624:flotation [Laboratory Procedure]

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 200,000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 22 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in a Sw40 rotor"

Phrase: "(Beckman"

Phrase: ")"

Phrase: ","

Phrase: "12 fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analyzed for protein content."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.138: Western blotting and quantifications were performed as described above. 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "quantifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709793:Quantification [Quantitative Concept]

Phrase: "were"

Phrase: "performed as described above."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.139: Results are represented as normalized histograms (42). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "represented as normalized histograms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1882115:Normalized [Research Activity]
   737   C1882932:Represent [Activity]
   737   C2348974:Histogram [Manufactured Object]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.140: View larger version (17K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.141: LiCl increases the level of CTF produced by CHO cells expressing human APP695. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the level of CTF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "produced by CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human APP695."
Processing 00000000.tx.142: CHO cells expressing human APP695 were incubated in the presence or absence of 5 mM LiCl for 24 h or 250 nM DAPT for 8 h. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 5 mM LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "250 nM DAPT for 8 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0634829:dapt [Lipid]
Processing 00000000.tx.143: A, expression of human APP695 was analyzed by Western blotting using the WO-2 antibody (upper panel). 

Phrase: "A,"

Phrase: "expression of human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the WO-2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.144: Cellular levels of CTF were analyzed after immunoprecipitation with the WO-2 antibody (lower panel). 

Phrase: "Cellular levels of CTF"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed after immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the WO-2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.145: B, the CTF/APP signal ratio was quantified and expressed (mean  S.E.) as percentage of nontreated (NT) controls; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the CTF/APP signal ratio"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C1707271:C-Terminal [Amino Acid Sequence]
   754   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C1168438:Protein C [Laboratory Procedure]
   754   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   754   C1418943:PROTEIN C [Gene or Genome]
   754   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205088:Terminal [Temporal Concept]
   738   C0332255:fragment [Functional Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "quantified"

Phrase: "and"

Phrase: "expressed"

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "as"

Phrase: "percentage of nontreated (NT) controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.146: n = 3; 

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.147: ***, p < 0.001 when compared with control.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.148: Statistical AnalysisThe number of samples (n) in each experimental condition is indicated in the legends to Figs. 

Phrase: "Statistical AnalysisThe number of samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(n) in each experimental condition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1553036:[n] [Quantitative Concept]

Phrase: "is"

Phrase: "indicated in the legends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   737   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Figs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0349966:Figs [Food]
   966 E C1337208:FIG [Food]
Processing 00000000.tx.149: 1, 2, 4, 5, 6, and 7. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "and"

Phrase: "7."
Processing 00000000.tx.150: Unpaired t test were performed to compare two experimental conditions. 

Phrase: "Unpaired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1710574:Unpaired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "two experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.151: Otherwise, statistical analysis was performed by one-way analysis of variance followed by Bonferroni's multiple comparison post-hoc test. 

Phrase: "Otherwise,"

Phrase: "statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by one-way analysis of variance"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   778   C1550369:Performed By [Qualitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by Bonferroni's multiple comparison post-hoc test."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]
   744   C1707455:Comparison [Activity]
   711 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.152: Each Western blot presented in Figs. 

Phrase: "Each Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "presented in Figs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]
   756 E C1337208:FIG [Food]
Processing 00000000.tx.153: 1, 2, 5, and 6 are representative of at least three independent experiments.  

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.154: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  LiCl Increases the Amount of A-(140) Produced by CHO Cells Expressing Human APP695Transfected CHO cells expressing human APP695 were analyzed by Western blotting using the WO-2 antibody. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Amount of A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: ")"

Phrase: "Produced by CHO Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "Expressing"

Phrase: "Human APP695Transfected CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the WO-2 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.155: The WO-2 antibody did not detect endogenous APP produced by CHO cells (Fig. 1A), confirming the specificity of this antibody for human APP isoforms (43). 

Phrase: "The WO-2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "endogenous APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "produced by CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of this antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0003264:Antibody Specificity [Molecular Function]
   762 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "for human APP isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.156: Results shown in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.157: 1A indicate that CHO cells expressing human APP695 produced sAPP as well as A in their culture medium. 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "indicate"

Phrase: "that CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "produced"

Phrase: "sAPP"

Phrase: "as well as"

Phrase: "A in their culture medium."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
Processing 00000000.tx.158: CHO cells were incubated for 24 h or 48 h in the presence of increasing concentrations of LiCl (0, 1, 2.5, 5, 10, 20 mM), and cell survival was measured by using the MTT assay. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "48 h in the presence of increasing concentrations of LiCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0033727:H+ [Element, Ion, or Isotope]
   738   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0441932:H+ [Classification]
   738   C0564385:/h [Quantitative Concept]
   737   C0020283:H+ concentration [Quantitative Concept]

Phrase: "(0,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "20 mM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.159: The results presented in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.160: 1B indicate that, after 24 h, LiCl induced a significant toxicity at 10 and 20 mM. 

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "indicate"

Phrase: "that,"

Phrase: "after"

Phrase: "24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant toxicity at 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "20 mM."
Processing 00000000.tx.161: After 48 h of incubation, 5 mM LiCl also induced a significant cell death. 

Phrase: "After 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation,"

Phrase: "5 mM LiCl also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   804   C0008203:Chloride, NOS [Inorganic Chemical]
   804   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: Therefore, LiCl was utilized at a maximal 5 mM concentration during 24 h. 

Phrase: "Therefore,"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "utilized at a maximal 5 mM concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086045:Concentration [Mental Process]
   748   C0205289:Maximal [Qualitative Concept]
   748   C0806909:Maximal [Quantitative Concept]
   748   C1446561:Concentration [Quantitative Concept]
   738   C2347813:Concentration Maximum [Quantitative Concept]

Phrase: "during 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.163: CHO cells were incubated for 24 h in the presence of increasing concentrations of LiCl (0, 1, 2.5, 5 mM), and the production of extracellular A was quantified by ELISA and normalized to the amount of sAPP. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(0,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "5 mM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the production of extracellular A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "quantified by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "normalized to the amount of sAPP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1265611:Amount [Quantitative Concept]
   753   C1882115:Normalized [Research Activity]
Processing 00000000.tx.164: The results presented in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.165: 1C indicate that LiCl increased the production of extracellular A-(140) in a concentration-dependent manner. 

Phrase: "1C"

Phrase: "indicate"

Phrase: "that LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the production of extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: ")"

Phrase: "in a concentration-dependent manner."
Processing 00000000.tx.166: A 24-h treatment of CHO cells with 5 mM LiCl increased the production of A-(140) by 67% without detectable cytotoxic effects. 

Phrase: "A 24-h treatment of CHO cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with 5 mM LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the production of A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: ")"

Phrase: "by 67%"

Phrase: "without detectable cytotoxic effects."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1280500:effects [Qualitative Concept]
   827   C1511636:cytotoxic [Functional Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.167: The culture medium of CHO cells incubated in the presence or absence of LiCl was recovered, and A was quantified by ELISA before and after a 24-h incubation at 37 C. 

Phrase: "The culture medium of CHO cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   783   C0007585:cells culture [Laboratory Procedure]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "was"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: ","

Phrase: "and"

Phrase: "A"

Phrase: "was"

Phrase: "quantified by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "before"

Phrase: "and after a 24-h incubation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "at 37 C."
Processing 00000000.tx.168: Results presented in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.169: 1D show an identical decrease of A in both experimental conditions indicating that LiCl treatment did not affect the turnover of A in the extracellular medium. 

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an identical decrease of A in both experimental conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "indicating"

Phrase: "that LiCl treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the turnover of A in the extracellular medium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.170: View larger version (19K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.171: LiCl does not change the subcellular localization of APP695 and BACE1. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the subcellular localization of APP695"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "BACE1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]
Processing 00000000.tx.172: CHO cells were incubated for 24 h in the presence or in the absence (CTL, control) of 5 mM LiCl. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(CTL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039195:CTL [Cell]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "of 5 mM LiCl."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]
Processing 00000000.tx.173: The particulate distribution of APP695 (C) and BACE1 (D) in sucrose density gradients was compared with that of early endosomes (transferrin internalized (Tf) for 5 min) (A) and the intermediate compartment of the secretory pathway between endoplasmic reticulum and cis-Golgi (p58)(B).  

Phrase: "The particulate distribution of APP695"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "BACE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]

Phrase: "("

Phrase: "D) in sucrose density gradients"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0178587:density [Quantitative Concept]
   760   C0812409:gradients [Quantitative Concept]
   760   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   726 E C0439182:% gradient [Quantitative Concept]

Phrase: "was"

Phrase: "compared with that of early endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0887883:Early endosome [Cell Component]
   753   C0034850:Endosomes [Cell Component]
   753   C1279919:Early [Temporal Concept]
   753   C1707455:Compared [Activity]

Phrase: "(transferrin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1442762:TRANSFERRIN [Gene or Genome]
   916 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "internalized"

Phrase: "(Tf) for 5 min) ("

Phrase: "A)"

Phrase: "and"

Phrase: "the intermediate compartment of the secretory pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205103:Intermediate [Spatial Concept]
   748   C1185625:Compartment [Body Space or Junction]
   748   C1550465:intermediate [Idea or Concept]
   748   C2827755:INTERMEDIATE [Laboratory or Test Result]
   748   C2986730:Compartment [Spatial Concept]

Phrase: "between endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "cis-Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018042:Golgi [Cell Component]

Phrase: "(p58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541311:P58 [Gene or Genome]

Phrase: ")"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.174: To investigate the effect of LiCl on GSK3 activity, we analyzed the cellular distribution of -catenin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on GSK3 activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the cellular distribution of -catenin."
Processing 00000000.tx.175: The phosphorylation of -catenin by GSK3 targets -catenin for proteasomal degradation, whereas the inhibition of GSK3 allows the binding of -catenin to transcription factors and its translocation to the nucleus (21). 

Phrase: "The phosphorylation of -catenin by GSK3 targets -catenin"

Phrase: "for proteasomal degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "whereas"

Phrase: "the inhibition of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the binding of -catenin to transcription factors"

Phrase: "and"

Phrase: "its translocation to the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.176: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.177: 1E, LiCl (5 mM, 24 h) induced the nuclear translocation of -catenin in CHO cells treated with LiCl, showing that GSK3 activity was inhibited under our experimental conditions. 

Phrase: "1E,"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(5 mM,"

Phrase: "24 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin in CHO cells"

Phrase: "treated with LiCl,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that GSK3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "inhibited under our experimental conditions."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]
Processing 00000000.tx.178: LiCl Increases the Amount of CTF Fragments Produced by CHO Cells Expressing Human APP695The effect of LiCl on the amyloidogenic processing of human APP695 in CHO cells was compared with that of DAPT, a known functional -secretase inhibitor (30). 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Amount of CTF Fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "Produced by CHO Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "Expressing"

Phrase: "Human APP695The effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the amyloidogenic processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of human APP695"

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "compared with that of DAPT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0634829:dapt [Lipid]
   760   C1707455:Compared [Activity]

Phrase: "a known functional -secretase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.179: DAPT and LiCl did not modify the expression of human APP695 in CHO cells (Fig. 2A). 

Phrase: "DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "and"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the expression of human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.180: As expected, -secretase inhibition by DAPT (250 nM, 8 h) resulted in the accumulation of CTF detected by Western blotting following its immunoprecipitation with the WO-2 antibody (Fig. 2A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ", -"

Phrase: "secretase inhibition by DAPT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "(250 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "8 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "resulted in the accumulation of CTF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1707271:C-Terminal [Amino Acid Sequence]
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]
   739   C3538722:APP [Laboratory Procedure]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "its immunoprecipitation with the WO-2 antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.181: LiCl treatment also induced CTF accumulation. 

Phrase: "LiCl treatment also induced CTF accumulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C1707271:C-Terminal [Amino Acid Sequence]
   738   C0205088:Terminal [Temporal Concept]
   738   C0332255:fragment [Functional Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.182: The effects of DAPT and LiCl on CTF accumulation were similar (3.2- and 2.8-fold increase, respectively). 

Phrase: "The effects of DAPT"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "LiCl on CTF accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   742   C0008203:Chloride, NOS [Inorganic Chemical]
   742   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "were"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(3.2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "2.8-fold increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.183: However, the processing of CTF that accumulated upon treatment was completely different in CHO cells treated with DAPT or LiCl. 

Phrase: "However,"

Phrase: "the processing of CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709694:Processing [Activity]

Phrase: "that"

Phrase: "accumulated upon treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "completely different in CHO cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "treated with DAPT"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0634829:dapt [Lipid]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "LiCl."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]
Processing 00000000.tx.184: Although DAPT strongly inhibited A production (not shown and Ref. 44), LiCl increased by 67% the amount of extracellular A-(140) (Fig. 1C). 

Phrase: "Although"

Phrase: "DAPT strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0634829:dapt [Lipid]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "Ref. 44"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased by 67%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the amount of extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.185: This led us to postulate that the CTF accumulation induced by LiCl did not result from the inhibition of -secretase activity but rather from an increased -cleavage of APP. 

Phrase: "This led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "postulate"

Phrase: "that"

Phrase: "the CTF accumulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragment [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "induced by LiCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0205263:Induced [Functional Concept]
   770   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result from the inhibition of -secretase activity"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C2825142:Result [Finding]
   748   C3463820:Inhibition [Activity]

Phrase: "but"

Phrase: "rather from an increased -cleavage of APP."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597304:Protein Cleavage [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1330957:cleavage [Cell Function]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.186: LiCl Does Not Change the Cellular Distribution of APP695 and BACE1One hypothesis could be that LiCl favors the -cleavage of APP by changing the cellular distribution of APP and BACE1, the protease known to cleave APP at the -site (14), so as to favor their encounter. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the Cellular Distribution of APP695"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "BACE1One hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "that LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the -cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "by changing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changing [Functional Concept]
  1000   C0443172:changing [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "the cellular distribution of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0872250:protein distribution [Cell Function]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "BACE1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]

Phrase: "the protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "APP at the -site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "so as to favor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037640:SO [Geographic Area]
   770   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "their encounter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Encounter [Behavior]
  1000   C1512346:encounter [Health Care Activity]
  1000   C1947978:Encounter [Behavior]
Processing 00000000.tx.187: This hypothesis was investigated by analytical subcellular fractionation using floatation in sucrose density gradients. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "was"

Phrase: "investigated by analytical subcellular fractionation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1656251:subcellular fractionation [Laboratory Procedure]
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C0936012:Analytical [Research Activity]
   760   C1292732:investigated [Functional Concept]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "floatation in sucrose density gradients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678624:flotation [Laboratory Procedure]
Processing 00000000.tx.188: Radiolabeled transferrin internalized for 5 min and p58 were used as markers of early endosomes and intermediate compartment/cis-Golgi, respectively (45, 46). 

Phrase: "Radiolabeled transferrin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "internalized for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "p58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541311:P58 [Gene or Genome]

Phrase: "were"

Phrase: "used as markers of early endosomes"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   773   C0887883:Early endosome [Cell Component]
   767   C1524063:Use of [Functional Concept]
   753   C0034850:Endosomes [Cell Component]
   753   C1273517:used [Finding]
   753   C1279919:Early [Temporal Concept]
   719   C0005516:Marker [Clinical Attribute]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "intermediate compartment/cis-Golgi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018042:Golgi [Cell Component]

Phrase: "respectively"

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.189: These two markers were clearly resorbed in the density gradients, and their distribution was not altered by LiCl treatment (Fig. 3, A and B). 

Phrase: "These two markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "clearly"

Phrase: "resorbed in the density gradients,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0178587:density [Quantitative Concept]
   760   C0812409:gradients [Quantitative Concept]
   726 E C0439182:% gradient [Quantitative Concept]

Phrase: "and"

Phrase: "their distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by LiCl treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   760   C0008203:Chloride, NOS [Inorganic Chemical]
   760   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0392747:Altered [Functional Concept]
   760   C0596019:Chloride [Element, Ion, or Isotope]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.190: The density distribution of APP695 and BACE1 analyzed in the same fractions (Fig. 3, C and D) was not affected either. 

Phrase: "The density distribution of APP695"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0178587:density [Quantitative Concept]
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "BACE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]

Phrase: "analyzed in the same fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0445247:Same [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "either."
Processing 00000000.tx.191: These data argued against the possibility that the increase in CTF production induced by LiCl resulted from a subcellular redistribution of APP695 and BACE1 along the intermediate secretory and/or endocytic pathways. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "argued against the possibility"

Phrase: "that"

Phrase: "the increase in CTF production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "induced by LiCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0205263:Induced [Functional Concept]
   770   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "resulted from a subcellular redistribution of APP695"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332620:Redistribution [Functional Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "BACE1 along the intermediate secretory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1412727:BACE1 [Gene or Genome]

Phrase: "and/or"

Phrase: "endocytic pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.192: View larger version (10K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.193: LiCl increases -secretase activity in CHO cells. 

Phrase: "LiCl increases -secretase activity in CHO cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.194: CHO cells were incubated in the presence or in the absence of 5 mM LiCl for 24 h or 250 nM DAPT for 8 h. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or in the absence of 5 mM LiCl"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   742   C0008203:Chloride, NOS [Inorganic Chemical]
   742   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0332197:absence [Quantitative Concept]
   742   C0596019:Chloride [Element, Ion, or Isotope]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "250 nM DAPT for 8 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0634829:dapt [Lipid]
Processing 00000000.tx.195: The -(A) and -secretase (B) activity were measured in cell extracts by FRET-based in vitro assays. 

Phrase: "The -(A)"

Phrase: "and -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(B) activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "in cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "extracts by FRET-based in vitro assays."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   780   C1515653:In Vitro Assay [Research Activity]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0597717:FRET [Laboratory Procedure]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2828366:Extract [Substance]
   714 E C0002055:base [Inorganic Chemical]
   714   C0005507:Assay [Laboratory Procedure]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]
   714 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.196: Results are expressed as percentage of untreated controls (NT); 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as percentage of untreated controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0332155:untreated [Finding]
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "(NT"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.197: n = 6; 

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.198: ***, p < 0.001 when compared with control. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.199: **, p < 0.01.  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.200: LiCl Increases -Secretase Activity in CHO CellsAlternatively, LiCl-mediated increase of CTF fragments production could result from a modification of the intrinsic -secretase activity. 

Phrase: "LiCl Increases -Secretase Activity in CHO CellsAlternatively,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "LiCl-mediated increase of CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "could"

Phrase: "result from a modification of the intrinsic -secretase activity."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205102:Intrinsic [Spatial Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0392747:Modification [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0439674:Intrinsic [Functional Concept]
   742   C0441655:Activity [Activity]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1554963:modification [Qualitative Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C2825142:Result [Finding]
Processing 00000000.tx.201: This activity was therefore measured in lysates of control and LiCl-treated cells by a FRET-based in vitro assay, using an APP-specific amino acid sequence as substrate. 

Phrase: "This activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "therefore"

Phrase: "measured in lysates of control"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0243148:control [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C1881488:Lysate [Physical Object]

Phrase: "and"

Phrase: "LiCl-treated cells by a FRET-based in vitro assay,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an APP-specific amino acid sequence as substrate."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C0002518:Amino Acid Sequence [Amino Acid Sequence]
           Protein Sequence
   777   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0202406:Acid [Laboratory Procedure]
   739   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.202: Preliminary controls were performed with purified -secretase and a -secretase inhibitor (40) to validate the assay (not shown). 

Phrase: "Preliminary controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "performed with purified -secretase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0884358:Performed [Functional Concept]
   770   C1998793:Purified [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "a -secretase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.203: Results show that a 24-h treatment with 5 mM LiCl significantly increased the -secretase activity in CHO cells (Fig. 4A). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a 24-h treatment with 5 mM LiCl significantly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the -secretase activity in CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.204: In addition, we also measured by in vitro assays the effects of LiCl treatment of CHO cells on -secretase activity. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we also"

Phrase: "measured by in vitro assays"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   828   C1515653:In Vitro Assay [Research Activity]
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "the effects of LiCl treatment of CHO cells on -secretase activity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   736   C1280500:effects [Qualitative Concept]
   734   C1518681:Treatment Effect [Finding]
   703 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.205: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.206: 4B, LiCl did not change -secretase activity, whereas DAPT inhibited the -secretase activity by 50%. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "secretase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the -secretase activity by 50%."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.207: Altogether, these results clearly establish that the treatment of CHO cells with LiCl increased -secretase activity without modifying -secretase activity. 

Phrase: "Altogether,"

Phrase: "these results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that"

Phrase: "the treatment of CHO cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "secretase activity without modifying -secretase activity."
Processing 00000000.tx.208: View larger version (42K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.209: LiCl inhibits GSK3 in rat cultured neurons. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3 in rat cultured neurons."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.210: Rat cultured neurons (APP) or neurons infected by a recombinant adenovirus encoding human APP695 (APP+) were analyzed by Western blotting using the WO-2 antibody. 

Phrase: "Rat cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "infected by a recombinant adenovirus encoding human APP695 (APP+)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   789   C1062667:Human adenovirus A [Virus]
   767   C0001490:Human adenovirus [Virus]
   744   C0001483:Adenovirus, NOS [Virus]
   744   C0001486:Adenovirus [Disease or Syndrome]
   744   C0086418:Human [Human]
   744   C0439663:Infected [Functional Concept]
   744   C1514798:recombinant [Organism]
   744   C1547699:Encoding [Idea or Concept]
   744   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C2700640:Encoding [Activity]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the WO-2 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.211: A, expression of APP in cellular extracts (upper left). 

Phrase: "A,"

Phrase: "expression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(upper left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.212: Protein loading was controlled by incubating membranes with an anti-actin antibody (lower left). 

Phrase: "Protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "controlled by incubating membranes"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   833   C0332298:Controlled by [Functional Concept]
   770   C0025255:Membranes [Tissue]
   770   C1439852:incubating [Laboratory Procedure]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1550141:Control [Substance]
   737 E C1706182:Membrane [Manufactured Object]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "with an anti-actin antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "(lower left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.213: Expression of sAPP (upper right) and detection of extracellular A after immunoprecipitation (lower right) are shown. 

Phrase: "Expression of sAPP (upper right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "detection of extracellular A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "after immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(lower right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.214: B, neuronal survival was measured using the MTT assay. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.215: Results (mean  S.E.) are given as the percentage of survival of untreated neurons (NT); 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "are"

Phrase: "given as the percentage of survival of untreated neurons"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   745   C1819944:neuron survival [Cell Function]
   742   C0027882:Neurons [Cell]
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   742   C0332155:untreated [Finding]
   742   C0439165:Percentage [Quantitative Concept]
   742   C1442162:GIVEN [Conceptual Entity]
   742   C1549488:Percentage [Idea or Concept]
   742   C1550718:given [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C3244317:given [Intellectual Product]
   708 E C1947971:Give [Functional Concept]

Phrase: "(NT"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.216: n = 20. 

Phrase: "n = 20."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.217: C, tau or phospho-tau (P-tau) were analyzed by Western blotting using the B19 (upper panel) or the PHF1 (lower panel) antibody. 

Phrase: "C,"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "or"

Phrase: "phospho-tau (P-tau)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the B19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3470196:B19 [Gene or Genome]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "the PHF1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418527:PHF1 [Gene or Genome]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.218: D, tau phosphorylation was quantified by measuring the PHF1/B19 signal ratio and expressed (mean  S.E.) as percentage of untreated neurons; 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "quantified by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the PHF1/B19 signal ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "expressed"

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "as"

Phrase: "percentage of untreated neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.219: n = 5; 

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.220: ***, p < 0.001 when compared with control. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.221: E, immunolabeling of untreated neurons or neurons incubated in the presence of LiCl with an anti--catenin antibody, indicating the LiCl-mediated concentration of -catenin in nuclei. 

Phrase: "E,"

Phrase: "immunolabeling of untreated neurons"

Phrase: "or"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "incubated in the presence of LiCl"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   748   C0008203:Chloride, NOS [Inorganic Chemical]
   748   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0596019:Chloride [Element, Ion, or Isotope]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "with an anti"

Phrase: "--"

Phrase: "catenin antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicating"

Phrase: "the LiCl-mediated concentration of -catenin in nuclei."
Processing 00000000.tx.222: Scale bars,10 m.  

Phrase: "Scale bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.223: Effects of LiCl on Neuronal Survival and GSK3 ActivityWe further analyzed the effects of LiCl on APP processing in neuronal cells. 

Phrase: "Effects of LiCl"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on Neuronal Survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "GSK3 ActivityWe further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the effects of LiCl"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.224: To that end, we infected rat cultured neurons with recombinant adenoviruses encoding human APP695 (33, 44). 

Phrase: "To"

Phrase: "that end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "rat cultured neurons with recombinant adenoviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human APP695"

Phrase: "(33,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.225: Fours days after infection, high levels of human full-length APP were detected in cell lysates of APP-infected neurons (Fig. 5A, left). 

Phrase: "Fours days after infection,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "high levels of human full-length APP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0428479:Protein level [Laboratory or Test Result]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in cell lysates of APP-infected neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.226: In the corresponding medium, sAPP and A were released (Fig. 5A, right). 

Phrase: "In the corresponding medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "sAPP"

Phrase: "and"

Phrase: "A"

Phrase: "were"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.227: The effect of LiCl on the neuronal survival was measured by MTT. 

Phrase: "The effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "measured by MTT."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0647210:mtt [Lipid]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.228: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.229: 5B, the LiCl treatment (5 mM, 24 h) had no neurotoxic effects. 

Phrase: "5B,"

Phrase: "the LiCl treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(5 mM,"

Phrase: "24 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "had"

Phrase: "no neurotoxic effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0235032:Neurotoxic effect [Injury or Poisoning]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.230: To investigate the effect of LiCl on neuronal GSK3 activity, we first analyzed the phosphorylation of the tau protein. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on neuronal GSK3 activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   947   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   901   C2261482:glycogen synthase kinase activity [Molecular Function]
   885   C1152133:glycogen synthase activity [Molecular Function]
   839   C1150423:kinase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the phosphorylation of the tau protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.231: Western blotting showed that the expression of tau, either phosphorylated or not phosphorylated, was similar in both controls and neurons treated with LiCl, as detected by the B19 antibody (Fig. 5C, upper panel, and Ref. 5). 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of tau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "either phosphorylated"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "phosphorylated"

Phrase: ","

Phrase: "was"

Phrase: "similar in both controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "treated with LiCl,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "detected by the B19 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C3470196:B19 [Gene or Genome]

Phrase: "(Fig. 5C,"

Phrase: "upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "Ref. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.232: By contrast, the detection of tau by the PHF1 antibody, which specifically recognizes phosphorylated tau, clearly showed a decrease in signal (Fig. 5C, lower panel) corresponding to a 45% decrease in tau phosphorylation when neurons were incubated with LiCl (Fig. 5D). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the detection of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by the PHF1 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which specifically"

Phrase: "recognizes"

Phrase: "phosphorylated tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "clearly"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a decrease in signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 5C,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "corresponding to a 45% decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "in tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "when"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated with LiCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.233: Moreover, as shown in Fig. 

Phrase: "Moreover,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.234: 5E, LiCl induced the nuclear translocation of -catenin in rat cortical neurons treated with LiCl, confirming the inhibition of GSK3 under our experimental conditions. 

Phrase: "5E,"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin in rat cortical neurons"

Phrase: "treated with LiCl,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the inhibition of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "under our experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.235: LiCl Increases the Amount of CTF, A, and BACE1 Protein in NeuronsWe studied the effect of LiCl on the amyloidogenic processing of human APP695 expressed in rat cultured neurons. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Amount of CTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "A,"

Phrase: "and"

Phrase: "BACE1 Protein in NeuronsWe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the amyloidogenic processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of human APP695"

Phrase: "expressed in rat cultured neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neurons [Cell]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
Processing 00000000.tx.236: Four days after infection with recombinant adenoviruses encoding human APP695, neurons were treated with LiCl (5 mM) for 24 h. 

Phrase: "Four days after infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "with recombinant adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0001483:Adenoviruses [Virus]
   861   C1514798:recombinant [Organism]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human APP695,"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "treated with LiCl"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(5 mM) for 24 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0456680:mm/h [Quantitative Concept]
Processing 00000000.tx.237: Cell lysates and culture media were subsequently analyzed by Western blotting with the WO-2 antibody. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "and"

Phrase: "culture media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0162867:Media [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1254021:Media [Tissue]
   861   C2242979:Culture [Laboratory Procedure]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "subsequently"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with the WO-2 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.238: LiCl modified neither the amount of cellular human APP695 nor the amount of soluble APP recovered in the culture medium (not shown). 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "neither the amount of cellular human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "nor"

Phrase: "the amount of soluble APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "recovered in the culture medium"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C0521108:recovered [Qualitative Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726 E C2004454:recover [Organism Function]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.239: The effect of LiCl on the amyloidogenic processing of human APP in rat cortical neurons was compared with that of DAPT. 

Phrase: "The effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the amyloidogenic processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "in rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "was"

Phrase: "compared with that of DAPT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0634829:dapt [Lipid]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.240: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.241: 6A and as in CHO cells, DAPT induced a 3-fold increase in CTF, detected by Western blotting following its immunoprecipitation with the WO-2 antibody. 

Phrase: "6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "and"

Phrase: "as in CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a 3-fold increase in CTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "its immunoprecipitation with the WO-2 antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.242: A 2-fold increase in CTF was also observed in the presence of LiCl (Fig. 6B). 

Phrase: "A 2-fold increase in CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed in the presence of LiCl"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   748   C0008203:Chloride, NOS [Inorganic Chemical]
   748   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0596019:Chloride [Element, Ion, or Isotope]
   748   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.243: The processing of accumulated CTF was completely different in neurons treated with DAPT or LiCl. 

Phrase: "The processing of accumulated CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "completely different in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "treated with DAPT"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0634829:dapt [Lipid]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "LiCl."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]
Processing 00000000.tx.244: As indicated in Fig. 

Phrase: "As"

Phrase: "indicated in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.245: 6C, DAPT completely inhibited A production, as described previously (44). 

Phrase: "6C,"

Phrase: "DAPT completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0634829:dapt [Lipid]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.246: By contrast, LiCl induced a 2-fold increase in extracellular A production. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a 2-fold increase in extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.247: Interestingly, LiCl significantly increased the amount of BACE1 protein in neuronal extracts (Fig. 6D). 

Phrase: "Interestingly,"

Phrase: "LiCl significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   827   C0008203:Chloride, NOS [Inorganic Chemical]
   827   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of BACE1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in neuronal extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(Fig. 6D"

Phrase: ")."
Processing 00000000.tx.248: Taken together, these results demonstrate that LiCl increases the production of extraneuronal A by increasing the amount of CTF, which is further processed by an unchanged -secretase activity, confirming in neurons the effect of LiCl observed in transfected CHO cells. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the production of extraneuronal A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "by increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of CTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "processed by an unchanged -secretase activity,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0442739:Unchanged [Finding]
   753   C1522240:Processed [Phenomenon or Process]
   753   C1561536:*Activity [Idea or Concept]
   753   C2346711:Unchanged [Qualitative Concept]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "confirming in neurons"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0521093:confirming [Qualitative Concept]
   790   C0750484:confirming [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "the effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "observed in transfected CHO cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.249: SB415286, a GSK3 Inhibitor, Does Not Significantly Modify the Production of Extracellular ALithium, frequently used as a noncompetitive inhibitor of GSK3, is not really specific and displays a number of other activities. 

Phrase: "SB415286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "a GSK3 Inhibitor,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Does"

Phrase: "Not Significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "Modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the Production of Extracellular ALithium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "used as a noncompetitive inhibitor of GSK3,"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033640:Glycogen synthase a kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1417673:glycogen synthase A kinase [Gene or Genome]
   795   C3537353:Glycogen Synthase A Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   757   C3537023:kinase inhibitor [Molecular Function]
   757   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   741   C1524063:Use of [Functional Concept]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1273517:used [Finding]
   739   C1999216:Inhibitor [Qualitative Concept]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "not really specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a number of other activities."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.250: To study whether the LiCl-mediated increase in neuronal A production was related to the inhibition of GSK3, we tested another GSK3 inhibitor. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "whether"

Phrase: "the LiCl-mediated increase in neuronal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "related to the inhibition of GSK3,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "another GSK3 inhibitor."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.251: SB415286 selectively inhibits GSK3 in a competitive manner with respect to ATP (37). 

Phrase: "SB415286 selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2713511:SB415286 [Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3 in a competitive manner"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   815   C0033640:Glycogen synthase a kinase [Amino Acid, Peptide, or Protein,Enzyme]
   815   C1417673:glycogen synthase A kinase [Gene or Genome]
   815   C3537353:Glycogen Synthase A Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with respect to ATP"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.252: Rat cultured neurons expressing human APP were incubated in the presence or absence of 25 M SB415286 for 24 h, and neuronal survival was measured by using the MTT assay. 

Phrase: "Rat cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 25 M SB415286"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.253: The results presented in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.254: 7A clearly indicate that SB415286 had no detectable neurotoxicity under these conditions. 

Phrase: "7A clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "indicate"

Phrase: "that SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "had"

Phrase: "no detectable neurotoxicity under these conditions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.255: Like LiCl, SB415286 induced the nuclear translocation of -catenin in neurons (Fig. 7B), confirming GSK3 inhibition. 

Phrase: "Like LiCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the nuclear translocation of -catenin in neurons"

Phrase: "(Fig. 7B"

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "GSK3 inhibition."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   733 E C0311403:Inhibited [Qualitative Concept]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.256: SB415286 did not modify the amount of human APP expressed by rat cultured neurons (not shown). 

Phrase: "SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the amount of human APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "expressed by rat cultured neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neurons [Cell]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.257: In contrast to LiCl, SB415286 tended to decrease extracellular A production, although the difference was not statistically significant (Fig. 7C). 

Phrase: "In contrast to LiCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "extracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "although"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "not statistically significant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(Fig. 7C"

Phrase: ")."
Processing 00000000.tx.258: Combined inhibition with LiCl and SB415286 increased A production in neurons by 46% as compared with SB415286 alone, indicating cumulative effects. 

Phrase: "Combined inhibition with LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "by 46%"

Phrase: "as"

Phrase: "compared with SB415286"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Compared [Activity]
   790   C2713511:SB415286 [Organic Chemical]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "indicating"

Phrase: "cumulative effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1280500:effects [Qualitative Concept]
   861   C1511559:Cumulative [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.259: Taken together, these results demonstrate that the LiCl-mediated increase in A production was independent of its inhibition of GSK3. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the LiCl-mediated increase in A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "was independent of its inhibition of GSK3."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332291:Independent of [Functional Concept]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0043194:WAS [Disease or Syndrome]
   739   C0085862:Independent [Idea or Concept]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1299583:Independent [Finding]
   739   C1421478:WAS [Gene or Genome]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.260: View larger version (27K): [in this window] [in a new window]  FIGURE 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 6."
Processing 00000000.tx.261: LiCl increases the amount of CTF, A, and BACE1 protein in rat cultured neurons. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of CTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "A,"

Phrase: "and"

Phrase: "BACE1 protein in rat cultured neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1569778:Bace1 protein, rat [Amino Acid, Peptide, or Protein,Enzyme]
   783   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.262: Rat cortical neurons expressing human APP695 (APP+) were incubated in the presence (+) or in the absence () of 250 nM DAPT for 8 h (A and C) or 5 mM LiCl for 24 h (BD). 

Phrase: "Rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "(APP+"

Phrase: ")"

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(+"

Phrase: ")"

Phrase: "or in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: ")"

Phrase: "of 250 nM DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0634829:dapt [Lipid]

Phrase: "for 8 h (A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "5 mM LiCl for 24 h (BD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   744   C0008203:Chloride, NOS [Inorganic Chemical]
   744   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.263: Cell extracts were analyzed by Western blotting. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "analyzed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.264: A and B, detection of CTF after immunoprecipitation with the WO-2 antibody (left). 

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "detection of CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "after immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with the WO-2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.265: The CTF/APP signal ratio was quantified and expressed (mean  S.E.) as percentage of untreated controls; 

Phrase: "The CTF/APP signal ratio"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C1707271:C-Terminal [Amino Acid Sequence]
   754   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C1168438:Protein C [Laboratory Procedure]
   754   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   754   C1418943:PROTEIN C [Gene or Genome]
   754   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205088:Terminal [Temporal Concept]
   738   C0332255:fragment [Functional Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "quantified"

Phrase: "and"

Phrase: "expressed"

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "as"

Phrase: "percentage of untreated controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.266: n = 4; 

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.267: ***, p < 0.001 when compared with control (right). 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.268: C, the extracellular A-(140) was quantified by ELISA. 

Phrase: "C,"

Phrase: "the extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: ")"

Phrase: "was"

Phrase: "quantified by ELISA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.269: Results are given as mean  S.E. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "given as mean"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0444504:Mean [Quantitative Concept]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.270: (left) of extracellular A-(140) (pg/ml) or expressed as percentage (right) of nontreated controls; 

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "of extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: ")"

Phrase: "(pg/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439297:pg/mL [Quantitative Concept]
   861   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "expressed as percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "of nontreated controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.271: n = 7; 

Phrase: "n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.272: ***, p < 0.0001 when compared with the control. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with the control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.273: D, expression of BACE1 protein in cellular extracts (upper left). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "expression of BACE1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1171362:expression protein [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(upper left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.274: Protein loading was controlled by incubating membranes with an anti-actin antibody (lower left). 

Phrase: "Protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "controlled by incubating membranes"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   833   C0332298:Controlled by [Functional Concept]
   770   C0025255:Membranes [Tissue]
   770   C1439852:incubating [Laboratory Procedure]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1550141:Control [Substance]
   737 E C1706182:Membrane [Manufactured Object]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "with an anti-actin antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "(lower left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205091:Left [Spatial Concept]
   861   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.275: The BACE1/actin signal ratio was quantified and expressed (mean  S.E.) as percentage of untreated controls (NT); 

Phrase: "The BACE1/actin signal ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "quantified"

Phrase: "and"

Phrase: "expressed"

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "as"

Phrase: "percentage of untreated controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "(NT"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.276: n = 4; 

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.277: ***, p < 0.001 when compared with control (right).   

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.278: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Our data indicate that, in both CHO cells and rat cortical neurons each expressing human APP695, treatment for 24 h with 5 mM LiCl was not toxic and inhibited GSK3 activity. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that,"

Phrase: "in both CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "each"

Phrase: "expressing"

Phrase: "human APP695,"

Phrase: "treatment for 24 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 5 mM LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "not toxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600688:toxic [Injury or Poisoning]
   861   C1407029:Toxic [Qualitative Concept]

Phrase: "and"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "GSK3 activity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.279: In these experimental conditions, LiCl increased the -secretase activity, generating more CTF that was processed by an unchanged -secretase activity. 

Phrase: "In these experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the -secretase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "generating"

Phrase: "more CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0332255:fragment [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "processed by an unchanged -secretase activity."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0442739:Unchanged [Finding]
   753   C1522240:Processed [Phenomenon or Process]
   753   C1561536:*Activity [Idea or Concept]
   753   C2346711:Unchanged [Qualitative Concept]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.280: Consequently, LiCl increased the production of extracellular A. 

Phrase: "Consequently,"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the production of extracellular A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.281: In contrast to the present study, several reports suggest that LiCl is able to inhibit A production in different cellular models, including cultured neurons (2629). 

Phrase: "In contrast to the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "several reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A production in different cellular models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(2629"

Phrase: ")."
Processing 00000000.tx.282: In some of these studies (26, 28, 29), however, transfected cells are treated with LiCl concentrations that we found to be cytotoxic, which could account for the reported decrease in A production. 

Phrase: "In some"

Phrase: "of these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(26,"

Phrase: "28,"

Phrase: "29"

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "treated with LiCl concentrations"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0008203:Chloride, NOS [Inorganic Chemical]
   760   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0596019:Chloride [Element, Ion, or Isotope]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cytotoxic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
  1000   C1511636:cytotoxic [Functional Concept]

Phrase: "which"

Phrase: "could"

Phrase: "account for the reported decrease"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "in A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.283: In mouse cortical neurons in which LiCl is found to block A production (27), expression of human APP695 is driven by recombinant Semliki Forest virus, which allows a very transient expression before inducing severe neuronal toxicity. 

Phrase: "In mouse cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in which LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "expression of human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "driven by recombinant Semliki Forest virus,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0036636:Semliki forest virus [Virus]
   783   C0597363:recombinant virus [Virus]
   753   C0042776:Virus [Virus]
   753   C0086312:Forest [Geographic Area]
   753   C0319157:virus [Virus]
   753   C1514798:recombinant [Organism]
   719   C0013126:Drive [Mental Process]

Phrase: "which"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "a very transient expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "before"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "severe neuronal toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.284: We have used recombinant adenoviruses that allow long-term APP expression without triggering toxic effects (33). 

Phrase: "We"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0001483:Adenoviruses [Virus]
   861   C1514798:recombinant [Organism]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "long-term APP expression without triggering toxic effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1171362:protein expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.285: In APP transgenic mice, lithium is also reported to cause a reduction in A production (2729). 

Phrase: "In APP transgenic mice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in A production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(2729"

Phrase: ")."
Processing 00000000.tx.286: However, lithium ions can affect in vivo several physiological mechanisms involved in APP processing. 

Phrase: "However,"

Phrase: "lithium ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C3495095:Lithium Ion [Element, Ion, or Isotope]
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "can"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "in vivo several physiological mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441712:Mechanisms [Functional Concept]
   771 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in APP processing."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]
Processing 00000000.tx.287: Therefore, it is difficult to compare these results with those obtained in cultured cells. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "these results with those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "obtained in cultured cells."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.288: In addition, it must be stressed that the transgenic mice studied expressed Swedish human APP (swAPP), a mutated form that favors amyloidogenic processing into A. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "must"

Phrase: "be"

Phrase: "stressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038435:stressed [Finding]

Phrase: "that"

Phrase: "the transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "expressed Swedish human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   858   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "(swAPP"

Phrase: ")"

Phrase: ","

Phrase: "a mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that favors amyloidogenic processing into A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]
Processing 00000000.tx.289: LiCl has also been reported to block A production in various cellular models expressing swAPP. 

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "A production in various cellular models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "expressing"

Phrase: "swAPP."
Processing 00000000.tx.290: However, it has been shown that the amyloidogenic processing of the wild-type APP is different from that of swAPP, in particular for the -cleavage (47) that we have demonstrated to be affected by LiCl. 

Phrase: "However,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the amyloidogenic processing of the wild-type APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0033666:protein processing [Molecular Function]
   757   C1547386:Processing type [Idea or Concept]
   739   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "different from that of swAPP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "in particular"

Phrase: "for the -cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "(47"

Phrase: ")"

Phrase: "that"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "affected by LiCl."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   770   C0008203:Chloride, NOS [Inorganic Chemical]
   770   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0392760:Affected [Functional Concept]
   770   C0596019:Chloride [Element, Ion, or Isotope]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
Processing 00000000.tx.291: We found that LiCl, contrary to DAPT, does not inhibit -secretase activity. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that LiCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "contrary to DAPT,"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.292: Although, LiCl could alter access of APP to the -secretase complex (27), our results suggest that LiCl-mediated accumulation of CTF most likely resulted from increased -cleavage of APP. 

Phrase: "Although"

Phrase: ","

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "could"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "access of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "to the -secretase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that LiCl-mediated accumulation"

Phrase: "of CTF most likely"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C1707271:C-Terminal [Amino Acid Sequence]
   793   C0205088:Terminal [Temporal Concept]
   793   C0332148:Likely [Qualitative Concept]
   793   C0332255:fragment [Functional Concept]
   793   C0332285:Of [Spatial Concept]
   793   C0750492:Likely [Idea or Concept]
   793   C1705314:Terminal [Manufactured Object]
   793   C1705315:Terminal [Spatial Concept]
   793   C1708096:Fragment [Qualitative Concept]
   793   C3538722:APP [Laboratory Procedure]

Phrase: "resulted from increased -cleavage of APP."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0597304:Protein Cleavage [Molecular Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0010813:cleavage [Cell Function]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1330957:cleavage [Cell Function]
   744   C1709634:Precursor [Idea or Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.293: We found no effect of LiCl on the subcellular distribution of APP and BACE1. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no effect of LiCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "BACE1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]
Processing 00000000.tx.294: Moreover, using FRET-based in vitro assays, we demonstrated directly that LiCl increases -secretase activity. 

Phrase: "Moreover,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FRET-based in vitro assays,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1515653:In Vitro Assay [Research Activity]
   840   C0021135:In Vitro [Intellectual Product]
   840   C1533691:in vitro [Qualitative Concept]
           vitro
   840   C2827718:In Vitro [Functional Concept]
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "that LiCl increases -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.295: Consistent with stimulation by LiCl of APP -cleavage, this treatment did not affect the production of extracellular A following adenoviral expression of C99 in rat cultured neurons (not shown). 

Phrase: "Consistent with stimulation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "by LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "of APP -cleavage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0597304:Protein Cleavage [Molecular Function]
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "this treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the production of extracellular A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "adenoviral expression of C99"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.296: This is in agreement with previous data indicating that 5 mM LiCl does not significantly decrease the secretion of A in COS cells transiently expressing C99 (26). 

Phrase: "This"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicating"

Phrase: "that 5 mM LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "does"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the secretion of A in COS cells transiently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C1327616:Cell secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "expressing"

Phrase: "C99"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.297: The mechanisms by which LiCl stimulates -secretase activity should be further investigated. 

Phrase: "The mechanisms by which LiCl"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "stimulates -"

Phrase: "secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "should"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.298: Treatment of primary cultures of neurons with 5 mM LiCl significantly increased their content in BACE1, suggesting that the increase in -secretase activity could result from an increase in BACE1 protein. 

Phrase: "Treatment of primary cultures of neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1708063:primary treatment [Therapeutic or Preventive Procedure]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with 5 mM LiCl significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   804   C0008203:Chloride, NOS [Inorganic Chemical]
   804   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "their content in BACE1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increase in -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "result from an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in BACE1 protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.299: We confirmed that LiCl efficiently inhibits GSK3 activity in CHO cells and neuronal cultures. 

Phrase: "We"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that LiCl efficiently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   827   C0008203:Chloride, NOS [Inorganic Chemical]
   827   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3 activity in CHO cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   869   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   822   C2261482:glycogen synthase kinase activity [Molecular Function]
   793   C1152133:glycogen synthase activity [Molecular Function]
   767   C1150423:kinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "neuronal cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.300: The role of GSK3 in A production is not clearly understood. 

Phrase: "The role of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "not clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.301: Inhibition of GSK3 is believed to reduce A production (28, 29). 

Phrase: "Inhibition of GSK3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.302: On the other hand, knocking down by small interfering RNAs demonstrated that the reduction of GSK3 levels reduced A production, whereas the reduction of GSK3 increased A production (27). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "knocking down"

Phrase: "by small interfering RNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the reduction of GSK3 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "whereas"

Phrase: "the reduction of GSK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.303: Because LiCl inhibits both GSK3 isoforms, this suggests that the effect of LiCl on A production could be dissociated from its inhibition of GSK3. 

Phrase: "Because"

Phrase: "LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both GSK3 isoforms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "this"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of LiCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "could"

Phrase: "be"

Phrase: "dissociated from its inhibition of GSK3."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.304: In addition to the inhibition of GSK3, lithium is known to display a number of other activities both in vitro and in vivo. 

Phrase: "In addition to the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a number of other activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.305: Under certain circumstances the cell physiology may shift the balance toward either the suppressive GSK3-dependent or the stimulatory GSK3-independent effect of LiCl on A production. 

Phrase: "Under certain circumstances"

Phrase: "the cell physiology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007613:Cell physiology [Cell Function]
  1000   C1325880:cell physiology [Cell Function]
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "may"

Phrase: "shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the balance toward either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]

Phrase: "the suppressive GSK3-dependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "the stimulatory GSK3-independent effect of LiCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0332291:Independent of [Functional Concept]
   738   C0085862:Independent [Idea or Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C1299583:Independent [Finding]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "on A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.306: View larger version (36K): [in this window] [in a new window]  FIGURE 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 7."
Processing 00000000.tx.307: GSK3 inhibitor (SB415286) does not modify neuronal production of A. 

Phrase: "GSK3 inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: ")"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "neuronal production of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]
Processing 00000000.tx.308: Rat cortical neurons expressing human APP695 were incubated for 24 h in the presence or in the absence (NT, no treatment) of 25 M SB415286. 

Phrase: "Rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "human APP695"

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(NT,"

Phrase: "no treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "of 25 M SB415286."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2713511:SB415286 [Organic Chemical]
Processing 00000000.tx.309: A, the neuronal survival was measured using the MTT assay. 

Phrase: "A,"

Phrase: "the neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.310: Neuronal survival (mean  S.E.) is represented as the percentage of nontreated controls; 

Phrase: "Neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "is"

Phrase: "represented as the percentage of nontreated controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882932:Represent [Activity]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.311: n = 24. 

Phrase: "n = 24."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.312: B, immunocytochemical analysis of untreated neurons (NT) or neurons incubated in the presence of SB415286 with an anti--catenin antibody, indicating the LiCl-mediated concentration of -catenin in nuclei. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "immunocytochemical analysis of untreated neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(NT"

Phrase: ")"

Phrase: "or"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "incubated in the presence of SB415286"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C2713511:SB415286 [Organic Chemical]

Phrase: "with an anti"

Phrase: "--"

Phrase: "catenin antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicating"

Phrase: "the LiCl-mediated concentration of -catenin in nuclei."
Processing 00000000.tx.313: Scale bars, 10 m. 

Phrase: "Scale bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.314: C, the extracellular A-(140) was quantified by ELISA in neuronal cultures treated with 5 mM LiCl, 25 M SB415286 (SB) or co-treated with LiCl and SB415286 (Li+SB) for 24 h. 

Phrase: "C,"

Phrase: "the extracellular A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521119:Extracellular [Cell Component]

Phrase: ")"

Phrase: "was"

Phrase: "quantified by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "in neuronal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "treated with 5 mM LiCl,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0008203:Chloride, NOS [Inorganic Chemical]
   753   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0596019:Chloride [Element, Ion, or Isotope]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "25 M SB415286 (SB)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2713511:SB415286 [Organic Chemical]

Phrase: "or"

Phrase: "co-treated with LiCl"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0008203:Chloride, NOS [Inorganic Chemical]
   760   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0596019:Chloride [Element, Ion, or Isotope]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "(Li+SB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2713511:SB415286 [Organic Chemical]

Phrase: ")"

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.315: Value (mean  S.E.) are given as percentage of nontreated controls; 

Phrase: "Value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "are"

Phrase: "given as percentage of nontreated controls"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1442162:GIVEN [Conceptual Entity]
   753   C1549488:Percentage [Idea or Concept]
   753   C1550718:given [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C3244317:given [Intellectual Product]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719 E C1947971:Give [Functional Concept]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.316: n = 6; 

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.317: *, p < 0.05 when compared with the control.  

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with the control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.318: We showed that SB415286, a more selective inhibitor of GSK3 than is LiCl, only slightly decreased the production of A. 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that SB415286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "a more selective inhibitor of GSK3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   762   C3537023:kinase inhibitor [Molecular Function]
   762   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "than"

Phrase: "is"

Phrase: "LiCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "only slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the production of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]
Processing 00000000.tx.319: Combined treatment of neurons with LiCl and SB415286 showed cumulative effects. 

Phrase: "Combined treatment of neurons"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   833   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with LiCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065088:Lithium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "SB415286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2713511:SB415286 [Organic Chemical]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cumulative effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1280500:effects [Qualitative Concept]
   861   C1511559:Cumulative [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.320: Therefore, these results demonstrate that the LiCl-mediated increase in A production is independent of its GSK3 inhibition. 

Phrase: "Therefore,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the LiCl-mediated increase in A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "is independent of its GSK3 inhibition."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0332291:Independent of [Functional Concept]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0085862:Independent [Idea or Concept]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1299583:Independent [Finding]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.321: Alzheimer disease is characterized by the presence in the brain of both extracellular senile plaques and intraneuronal neurofibrillary tangles. 

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "characterized by the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1880022:Characterized [Activity]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of both extracellular senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "intraneuronal neurofibrillary tangles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.322: The amyloid core of senile plaques contains the amyloid- peptide, and neurofibrillary tangles are made of paired helical filaments containing the hyperphosphorylated microtubule-associated protein tau. 

Phrase: "The amyloid core of senile plaques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0444669:Core [Spatial Concept]
   753   C1167518:core [Cell Component]
   753   C1706352:Core [Medical Device]
   753   C1882467:Core [Manufactured Object]
   753   C3274653:Core [Body Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the amyloid- peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "made of paired helical filaments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   828   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   760   C1709450:Paired [Qualitative Concept]
   726   C0010851:Filament [Cell Component]
   726   C1881534:Make [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the hyperphosphorylated microtubule-associated protein tau."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   937   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
   937   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   888   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1421563:protein tau [Gene or Genome]
   804   C0026046:Micro-tubule [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C1720655:Tau [Intellectual Product]
   804   C1947974:Tau [Research Activity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.323: To inhibit the formation of these typical lesions, the ideal therapeutic approach should prevent both amyloid and tau pathologies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the formation of these typical lesions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "the ideal therapeutic approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "should"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "both amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tau pathologies."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0030664:Pathologies [Biomedical Occupation or Discipline]
   827 E C0205469:pathology [Functional Concept]
   827 E C0677042:pathology [Pathologic Function]
   777 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.324: Lithium was shown to inhibit the phosphorylation of different substrates of GSK3, including tau, as well as to decrease the production of amyloid- peptide. 

Phrase: "Lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the phosphorylation of different substrates of GSK3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "as well as"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the production of amyloid- peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.325: Therefore, lithium could be considered as a powerful therapeutic agent for the treatment of Alzheimer disease. 

Phrase: "Therefore,"

Phrase: "lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "considered as a powerful therapeutic agent"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0304231:Therapeutic agent [Intellectual Product]
   790   C1611640:Therapeutic agent [Pharmacologic Substance]
   753   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   753   C0302350:Therapeutic [Functional Concept]
   753   C0450442:Agent [Chemical Viewed Functionally]
   753   C0750591:considered [Idea or Concept]
   753   C1254351:Agent [Pharmacologic Substance]
   753   C1521826:Agent [Intellectual Product]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.326: However, we have demonstrated in this paper that in two cell types expressing human APP695, lithium, when used at noncytotoxic concentrations, actually led to increased production of amyloid- peptide by increasing the -secretase activity. 

Phrase: "However,"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated in this paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030351:Paper [Manufactured Object]
   770   C1547566:Paper [Idea or Concept]

Phrase: "that in two cell types"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0205448:Two [Quantitative Concept]
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "expressing"

Phrase: "human APP695,"

Phrase: "lithium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "when"

Phrase: "used at noncytotoxic concentrations,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "actually"

Phrase: "led to increased production of amyloid- peptide"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   757   C0861064:increased lead [Finding]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0033268:production [Occupational Activity]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.327: The prospect of using lithium in therapeutic approaches therefore needs substantial revision.  

Phrase: "The prospect of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "lithium in therapeutic approaches therefore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "substantial revision."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439617:Revision [Temporal Concept]
   861   C0558347:Revision [Therapeutic or Preventive Procedure]
   861   C1527075:Revision [Therapeutic or Preventive Procedure]
Processing 00000000.tx.328: FOOTNOTES  * This work was supported by the Belgian Fonds pour la Formation  la Recherche dans l'Industrie et dans l'Agriculture (to C. F.), the Communaut Franaise de Belgique, Actions de Recherche Concertes (to P. K.-C.), the Belgian Fonds de la Recherche Scientifique Mdicale, and the Queen Elisabeth Medical Foundation and Alzheimer Belgique. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Belgian Fonds"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0337797:belgian [Population Group]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "pour"

Phrase: "la Formation  la Recherche dans l'Industrie et dans l'Agriculture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0001829:Agriculture [Occupation or Discipline]

Phrase: "("

Phrase: "to C. F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the Communaut Franaise de Belgique,"

Phrase: "Actions de Recherche Concertes"

Phrase: "("

Phrase: "to P. K.-C."

Phrase: ")"

Phrase: ","

Phrase: "the Belgian Fonds de la Recherche Scientifique Mdicale,"

Phrase: "and"

Phrase: "the Queen Elisabeth Medical Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "Alzheimer Belgique."
Processing 00000000.tx.329: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.330: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.331: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.332: 1 To whom correspondence should be addressed: Universit catholique de Louvain, Laboratoire de pharmacologie exprimentale (54 10), av Hippocrate 54, B-1200 Brussels, Belgium. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Universit catholique de Louvain,"

Phrase: "Laboratoire de pharmacologie exprimentale"

Phrase: "(54 10"

Phrase: ")"

Phrase: ","

Phrase: "av Hippocrate 54,"

Phrase: "B-1200 Brussels,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.333: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.334: 32-2-7649341; 

Phrase: "32-2-7649341"

Phrase: ";"
Processing 00000000.tx.335: Fax: 32-2-7645460; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "32-2-7645460"

Phrase: ";"
Processing 00000000.tx.336: E-mail: octave{at}nchm.ucl.ac.be . 2 The abbreviations used are: PHF, paired helical filament; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "octave{at}nchm.ucl."

Phrase: "ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "be . 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PHF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "paired helical filament"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.337: GSK3, glycogen synthase kinase 3; 

Phrase: "GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.338: A, amyloid- peptide; 

Phrase: "A,"

Phrase: "amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.339: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.340: sAPP, soluble -amyloid precursor protein; 

Phrase: "sAPP,"

Phrase: "soluble -amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C1749467:soluble [Cell Component]
   812   C1948047:Soluble [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.341: BACE1, -site APP-cleaving enzyme 1; 

Phrase: "BACE1, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE1 [Gene or Genome]

Phrase: "site APP-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.342: CTF, C-terminal fragment of APP produced by -cleavage; 

Phrase: "CTF,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1707271:C-Terminal [Amino Acid Sequence]
   760   C0205088:Terminal [Temporal Concept]
   760   C0332255:fragment [Functional Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "C-terminal fragment of APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   774   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1168438:Protein C [Laboratory Procedure]
   774   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   774   C1418943:PROTEIN C [Gene or Genome]
   774   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragment [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "produced by -cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: ";"
Processing 00000000.tx.343: DAPT, N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine tert-butyl ester; 

Phrase: "DAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "N-[N-(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441922:N+ [Intellectual Product]
   827   C1553036:[n] [Quantitative Concept]

Phrase: "5-difluorophenacetyl-L-alanyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ")"

Phrase: "]-"

Phrase: "S-"

Phrase: "phenylglycine tert-butyl ester"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0014898:Ester [Organic Chemical]
   812   C0754515:TERT [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1367342:TERT [Gene or Genome]
   812   C1705316:TERT [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.344: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltretrazolium bromide; 

Phrase: "MTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltretrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.345: CHO, Chinese hamster ovary; 

Phrase: "CHO,"

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.346: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.347: bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; 

Phrase: "bis-Tris,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0053809:Bis-Tris [Organic Chemical]
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0556985:BIS [Temporal Concept]
   861   C0814229:TRI [Intellectual Product]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[bis(2-hydroxyethyl"

Phrase: ")"

Phrase: "amino"

Phrase: "]-2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(hydroxymethyl"

Phrase: ")"

Phrase: "propane-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033434:Propane [Organic Chemical]

Phrase: "3-diol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017945:diol [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.348: FRET, fluorescence resonance energy transfer.  

Phrase: "FRET,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597717:FRET [Laboratory Procedure]

Phrase: "fluorescence resonance energy transfer."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]
Processing 00000000.tx.349: ACKNOWLEDGMENTS  We thank A. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.350: Goffinet for the generous gift of the SB415286, L. 

Phrase: "Goffinet for the generous gift of the SB415286,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.351: Mercken for kindly providing us with DAPT, J. 

Phrase: "Mercken for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with DAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0634829:dapt [Lipid]

Phrase: "J."
Processing 00000000.tx.352: Saraste for the generous gift of anti-p58 antibodies, P. 

Phrase: "Saraste for the generous gift of anti-p58 antibodies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.353: Davies for providing the PHF-1 antibody, B. 

Phrase: "Davies for providing"

Phrase: "the PHF-1 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.354: Tasiaux for excellent technical assistance, and M. 

Phrase: "Tasiaux for excellent technical assistance,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: Rider for the critical reading of the manuscript.  

Phrase: "Rider for the critical reading of the manuscript."
Processing 00000000.tx.356: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Braak, H., and Braak, E. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Braak,"

Phrase: "E."
Processing 00000000.tx.357: (1991) Acta Neuropathol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.358: (Berl.) 

Phrase: "(Berl."

Phrase: ")"
Processing 00000000.tx.359: 82, 239259[CrossRef][Medline] [OrderarticleviaInfotrieve] Brion, J. 

Phrase: "82,"

Phrase: "239259"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brion,"

Phrase: "J."
Processing 00000000.tx.360: P., Couck, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Couck,"

Phrase: "A."
Processing 00000000.tx.361: M., Passareiro, E., and Flament-Durand, J. 

Phrase: "M."

Phrase: ","

Phrase: "Passareiro,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Flament-Durand,"

Phrase: "J."
Processing 00000000.tx.362: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.363: Submicrosc. 

Phrase: "Submicrosc."
Processing 00000000.tx.364: Cytol. 

Phrase: "Cytol."
Processing 00000000.tx.365: 17, 8996[Medline] [OrderarticleviaInfotrieve] Delacourte, A., and Defossez, A. 

Phrase: "17,"

Phrase: "8996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Delacourte,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Defossez,"

Phrase: "A."
Processing 00000000.tx.366: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.367: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.368: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.369: 76, 173186[CrossRef][Medline] [OrderarticleviaInfotrieve] Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. 

Phrase: "76,"

Phrase: "173186"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iqbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Quinlan,"

Phrase: "M."

Phrase: ","

Phrase: "Tung,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330603:Tung [Plant]

Phrase: "Y."
Processing 00000000.tx.370: C., Zaidi, M. 

Phrase: "C., Zaidi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: S., and Wisniewski, H. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.372: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.374: Biol. 

Phrase: "Biol."
Processing 00000000.tx.375: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.376: 261, 60846089[Abstract/Free FullText] Brion, J. 

Phrase: "261,"

Phrase: "60846089"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brion,"

Phrase: "J."
Processing 00000000.tx.377: P., Hanger, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hanger,"

Phrase: "D."
Processing 00000000.tx.378: P., Couck, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Couck,"

Phrase: "A."
Processing 00000000.tx.379: M., and Anderton, B. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.380: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.381: (1991) Biochem. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.382: J. 

Phrase: "J."
Processing 00000000.tx.383: 279, 831836[Medline] [OrderarticleviaInfotrieve] Reynolds, C. 

Phrase: "279,"

Phrase: "831836"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Reynolds,"

Phrase: "C."
Processing 00000000.tx.384: H., Betts, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Betts,"

Phrase: "J."
Processing 00000000.tx.385: C., Blackstock, W. 

Phrase: "C., Blackstock,"

Phrase: "W."
Processing 00000000.tx.386: P., Nebreda, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nebreda,"

Phrase: "A."
Processing 00000000.tx.387: R., and Anderton, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.388: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.389: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.391: 74, 15871595[CrossRef][Medline] [OrderarticleviaInfotrieve] Sperber, B. 

Phrase: "74,"

Phrase: "15871595"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sperber,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.392: R., Leight, S., Goedert, M., and Lee, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Leight,"

Phrase: "S."

Phrase: ","

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.393: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: (1995) Neurosci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.395: Lett. 

Phrase: "Lett."
Processing 00000000.tx.396: 197, 149153[CrossRef][Medline] [OrderarticleviaInfotrieve] Hanger, D. 

Phrase: "197,"

Phrase: "149153"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hanger,"

Phrase: "D."
Processing 00000000.tx.397: P., Hughes, K., Woodgett, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.398: R., Brion, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Brion,"

Phrase: "J."
Processing 00000000.tx.399: P., and Anderton, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.400: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.401: (1992) Neurosci. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.402: Lett. 

Phrase: "Lett."
Processing 00000000.tx.403: 147, 5862[CrossRef][Medline] [OrderarticleviaInfotrieve] Lovestone, S., Reynolds, C. 

Phrase: "147,"

Phrase: "5862"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Reynolds,"

Phrase: "C."
Processing 00000000.tx.404: H., Latimer, D., Davis, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Latimer,"

Phrase: "D."

Phrase: ","

Phrase: "Davis,"

Phrase: "D."
Processing 00000000.tx.405: R., Anderton, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.406: H., Gallo, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gallo,"

Phrase: "J."
Processing 00000000.tx.407: M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J. 

Phrase: "M."

Phrase: ","

Phrase: "Hanger,"

Phrase: "D."

Phrase: ","

Phrase: "Mulot,"

Phrase: "S."

Phrase: ","

Phrase: "Marquardt,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stabel,"

Phrase: "S."

Phrase: ","

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.408: R., and Miller, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.409: J. 

Phrase: "J."
Processing 00000000.tx.410: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.411: Biol. 

Phrase: "Biol."
Processing 00000000.tx.412: 4, 10771086[CrossRef][Medline] [OrderarticleviaInfotrieve] Masters, C. 

Phrase: "4,"

Phrase: "10771086"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.413: L., Simms, G., Weinman, N. 

Phrase: "L., Simms,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Weinman,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.414: A., Multhaup, G., McDonald, B. 

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McDonald,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.415: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.416: (1985) Proc. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.417: Natl. 

Phrase: "Natl."
Processing 00000000.tx.418: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.419: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.420: U. 

Phrase: "U."
Processing 00000000.tx.421: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.422: A. 

Phrase: "A."
Processing 00000000.tx.423: 82, 42454249[Abstract/Free FullText] Kang, J., Lemaire, H. 

Phrase: "82,"

Phrase: "42454249"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.424: G., Unterbeck, A., Salbaum, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.425: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.426: L., Grzeschik, K. 

Phrase: "L., Grzeschik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.427: H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Muller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.428: (1987) Nature 325, 733736[CrossRef][Medline] [OrderarticleviaInfotrieve] Octave, J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Octave,"

Phrase: "J."
Processing 00000000.tx.429: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.430: (1995) Acta Neurol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Acta Neurol."
Processing 00000000.tx.431: Belg. 

Phrase: "Belg."
Processing 00000000.tx.432: 95, 197209[Medline] [OrderarticleviaInfotrieve] Octave, J. 

Phrase: "95,"

Phrase: "197209"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Octave,"

Phrase: "J."
Processing 00000000.tx.433: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.434: (1995) Rev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.435: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.436: 6, 287316[Medline] [OrderarticleviaInfotrieve] Vassar, R., Bennett, B. 

Phrase: "6,"

Phrase: "287316"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vassar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.437: D., Babu-Khan, S., Kahn, S., Mendiaz, E. 

Phrase: "D."

Phrase: ","

Phrase: "Babu-Khan,"

Phrase: "S."

Phrase: ","

Phrase: "Kahn,"

Phrase: "S."

Phrase: ","

Phrase: "Mendiaz,"

Phrase: "E."
Processing 00000000.tx.438: A., Denis, P., Teplow, D. 

Phrase: "A.,"

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.439: B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Loeloff,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Fuller,"

Phrase: "J.,"

Phrase: "Edenson,"

Phrase: "S."

Phrase: ","

Phrase: "Lile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1688274:Lile [Fish]

Phrase: "J.,"

Phrase: "Jarosinski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: A., Biere, A. 

Phrase: "A.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.441: L., Curran, E., Burgess, T., Louis, J. 

Phrase: "L., Curran,"

Phrase: "E.,"

Phrase: "Burgess,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.442: C., Collins, F., Treanor, J., Rogers, G., and Citron, M. 

Phrase: "C., Collins,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Treanor,"

Phrase: "J.,"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.443: (1999) Science 286, 735741[Abstract/Free FullText] De Strooper, B. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "735741"

Phrase: "[Abstract/Free FullText"

Phrase: "] De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.444: (2003) Neuron 38, 912[CrossRef][Medline] [OrderarticleviaInfotrieve] Edbauer, D., Winkler, E., Regula, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 38,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "912"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Winkler,"

Phrase: "E.,"

Phrase: "Regula,"

Phrase: "J."
Processing 00000000.tx.445: T., Pesold, B., Steiner, H., and Haass, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.446: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.447: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.448: 5, 486488[CrossRef][Medline] [OrderarticleviaInfotrieve] Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "486488"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Kojro,"

Phrase: "E.,"

Phrase: "Postina,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Pfeiffer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jasionowski,"

Phrase: "M."

Phrase: ","

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Fahrenholz,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.449: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.450: Natl. 

Phrase: "Natl."
Processing 00000000.tx.451: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.452: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.453: U. 

Phrase: "U."
Processing 00000000.tx.454: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.455: A. 

Phrase: "A."
Processing 00000000.tx.456: 96, 39223927[Abstract/Free FullText] Aplin, A. 

Phrase: "96,"

Phrase: "39223927"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aplin,"

Phrase: "A."
Processing 00000000.tx.457: E., Gibb, G. 

Phrase: "E.,"

Phrase: "Gibb,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.458: M., Jacobsen, J. 

Phrase: "M."

Phrase: ","

Phrase: "Jacobsen,"

Phrase: "J."
Processing 00000000.tx.459: S., Gallo, J. 

Phrase: "S."

Phrase: ","

Phrase: "Gallo,"

Phrase: "J."
Processing 00000000.tx.460: M., and Anderton, B. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.461: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.462: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.463: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.464: 67, 699707[Medline] [OrderarticleviaInfotrieve] Iijima, K., Ando, K., Takeda, S., Satoh, Y., Seki, T., Itohara, S., Greengard, P., Kirino, Y., Nairn, A. 

Phrase: "67,"

Phrase: "699707"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iijima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ando,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "S."

Phrase: ","

Phrase: "Satoh,"

Phrase: "Y.,"

Phrase: "Seki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272348:Seki [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Itohara,"

Phrase: "S."

Phrase: ","

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "Nairn,"

Phrase: "A."
Processing 00000000.tx.465: C., and Suzuki, T. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.466: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.468: 75, 10851091[CrossRef][Medline] [OrderarticleviaInfotrieve] Standen, C. 

Phrase: "75,"

Phrase: "10851091"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Standen,"

Phrase: "C."
Processing 00000000.tx.469: L., Brownlees, J., Grierson, A. 

Phrase: "L., Brownlees,"

Phrase: "J.,"

Phrase: "Grierson,"

Phrase: "A."
Processing 00000000.tx.470: J., Kesavapany, S., Lau, K. 

Phrase: "J.,"

Phrase: "Kesavapany,"

Phrase: "S."

Phrase: ","

Phrase: "Lau,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.471: F., McLoughlin, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "McLoughlin,"

Phrase: "D."
Processing 00000000.tx.472: M., and Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.473: C. 

Phrase: "C."
Processing 00000000.tx.474: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.475: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.476: 76, 316320[CrossRef][Medline] [OrderarticleviaInfotrieve] van Noort, M., Meeldijk, J., van der Zee, R., Destree, O., and Clevers, H. 

Phrase: "76,"

Phrase: "316320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] van Noort,"

Phrase: "M."

Phrase: ","

Phrase: "Meeldijk,"

Phrase: "J.,"

Phrase: "van der Zee,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Destree,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Clevers,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.477: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.478: Biol. 

Phrase: "Biol."
Processing 00000000.tx.479: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.480: 277, 1790117905[Abstract/Free FullText] Stambolic, V., Ruel, L., and Woodgett, J. 

Phrase: "277,"

Phrase: "1790117905"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stambolic,"

Phrase: "V.,"

Phrase: "Ruel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.481: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.482: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: 6, 16641668[CrossRef][Medline] [OrderarticleviaInfotrieve] Munoz-Montano, J. 

Phrase: "6,"

Phrase: "16641668"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Munoz-Montano,"

Phrase: "J."
Processing 00000000.tx.485: R., Moreno, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Moreno,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.486: J., Avila, J., and Diaz-Nido, J. 

Phrase: "J.,"

Phrase: "Avila,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Diaz-Nido,"

Phrase: "J."
Processing 00000000.tx.487: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.488: 411, 183188[CrossRef][Medline] [OrderarticleviaInfotrieve] Hong, M., Chen, D. 

Phrase: "411,"

Phrase: "183188"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "D."
Processing 00000000.tx.489: C., Klein, P. 

Phrase: "C., Klein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.490: S., and Lee, V. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.491: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.493: Biol. 

Phrase: "Biol."
Processing 00000000.tx.494: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.495: 272, 2532625332[Abstract/Free FullText] Lovestone, S., Davis, D. 

Phrase: "272,"

Phrase: "2532625332"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Davis,"

Phrase: "D."
Processing 00000000.tx.496: R., Webster, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Webster,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.497: T., Kaech, S., Brion, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kaech,"

Phrase: "S."

Phrase: ","

Phrase: "Brion,"

Phrase: "J."
Processing 00000000.tx.498: P., Matus, A., and Anderton, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Matus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1208001:Matus [Eukaryote]

Phrase: "A.,"

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.499: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.500: (1999) Biol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.501: Psychiatry 45, 9951003[CrossRef][Medline] [OrderarticleviaInfotrieve] Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J. 

Phrase: "Psychiatry 45,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "9951003"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "J."
Processing 00000000.tx.502: M., Yamaguchi, H., and Takashima, A. 

Phrase: "M."

Phrase: ","

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.503: (2002) Neurosci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.504: Lett. 

Phrase: "Lett."
Processing 00000000.tx.505: 321, 6164[CrossRef][Medline] [OrderarticleviaInfotrieve] Phiel, C. 

Phrase: "321,"

Phrase: "6164"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Phiel,"

Phrase: "C."
Processing 00000000.tx.506: J., Wilson, C. 

Phrase: "J.,"

Phrase: "Wilson,"

Phrase: "C."
Processing 00000000.tx.507: A., Lee, V. 

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.508: M., and Klein, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Klein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.509: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.510: (2003) Nature 423, 435439[CrossRef][Medline] [OrderarticleviaInfotrieve] Su, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., Brune, K., Paul, S., Zhou, Y., Liu, F., and Ni, B. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 423,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "435439"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Ryder,"

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "X.,"

Phrase: "Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Solenberg,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brune,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Paul,"

Phrase: "S."

Phrase: ","

Phrase: "Zhou,"

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Ni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.511: (2004) Biochemistry 43, 68996908[CrossRef][Medline] [OrderarticleviaInfotrieve] Ryder, J., Su, Y., Liu, F., Li, B., Zhou, Y., and Ni, B. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochemistry 43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "68996908"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ryder,"

Phrase: "J.,"

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zhou,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Ni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.512: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.513: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.514: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.515: Commun. 

Phrase: "Commun."
Processing 00000000.tx.516: 312, 922929[CrossRef][Medline] [OrderarticleviaInfotrieve] Dovey, H. 

Phrase: "312,"

Phrase: "922929"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dovey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.517: F., John, V., Anderson, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "John,"

Phrase: "V.,"

Phrase: "Anderson,"

Phrase: "J."
Processing 00000000.tx.518: P., Chen, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.519: Z., de Saint, A. 

Phrase: "Z.,"

Phrase: "de Saint,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242823:Saint [Conceptual Entity]

Phrase: "A."
Processing 00000000.tx.520: P., Fang, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227136:Fang [Body Part, Organ, or Organ Component]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.521: Y., Freedman, S. 

Phrase: "Y.,"

Phrase: "Freedman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.522: B., Folmer, B., Goldbach, E., Holsztynska, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Folmer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goldbach,"

Phrase: "E.,"

Phrase: "Holsztynska,"

Phrase: "E."
Processing 00000000.tx.523: J., Hu, K. 

Phrase: "J.,"

Phrase: "Hu,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.524: L., Johnson-Wood, K. 

Phrase: "L., Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0043217:Wood [Substance]
   771 E C0144237:Sylvan [Organic Chemical]
   743 E C0442548:Woods [Geographic Area]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.525: L., Kennedy, S. 

Phrase: "L., Kennedy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.526: L., Kholodenko, D., Knops, J. 

Phrase: "L., Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Knops,"

Phrase: "J."
Processing 00000000.tx.527: E., Latimer, L. 

Phrase: "E.,"

Phrase: "Latimer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.528: H., Lee, M., Liao, Z., Lieberburg, I. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Liao,"

Phrase: "Z.,"

Phrase: "Lieberburg,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.529: M., Motter, R. 

Phrase: "M."

Phrase: ","

Phrase: "Motter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.530: N., Mutter, L. 

Phrase: "N., Mutter,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.531: C., Nietz, J., Quinn, K. 

Phrase: "C., Nietz,"

Phrase: "J.,"

Phrase: "Quinn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.532: P., Sacchi, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sacchi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.533: L., Seubert, P. 

Phrase: "L., Seubert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.534: A., Shopp, G. 

Phrase: "A.,"

Phrase: "Shopp,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.535: M., Thorsett, E. 

Phrase: "M."

Phrase: ","

Phrase: "Thorsett,"

Phrase: "E."
Processing 00000000.tx.536: D., Tung, J. 

Phrase: "D."

Phrase: ","

Phrase: "Tung,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330603:Tung [Plant]

Phrase: "J."
Processing 00000000.tx.537: S., Wu, J., Yang, S., Yin, C. 

Phrase: "S."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S."

Phrase: ","

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.538: T., Schenk, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.539: B., May, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "May,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.540: C., Altstiel, L. 

Phrase: "C., Altstiel,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.541: D., Bender, M. 

Phrase: "D."

Phrase: ","

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.542: H., Boggs, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Boggs,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.543: N., Britton, T. 

Phrase: "N., Britton,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.544: C., Clemens, J. 

Phrase: "C., Clemens,"

Phrase: "J."
Processing 00000000.tx.545: C., Czilli, D. 

Phrase: "C., Czilli,"

Phrase: "D."
Processing 00000000.tx.546: L., Dieckman-McGinty, D. 

Phrase: "L., Dieckman-McGinty,"

Phrase: "D."
Processing 00000000.tx.547: K., Droste, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Droste,"

Phrase: "J."
Processing 00000000.tx.548: J., Fuson, K. 

Phrase: "J.,"

Phrase: "Fuson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.549: S., Gitter, B. 

Phrase: "S."

Phrase: ","

Phrase: "Gitter,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.550: D., Hyslop, P. 

Phrase: "D."

Phrase: ","

Phrase: "Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.551: A., Johnstone, E. 

Phrase: "A.,"

Phrase: "Johnstone,"

Phrase: "E."
Processing 00000000.tx.552: M., Li, W. 

Phrase: "M."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "W."
Processing 00000000.tx.553: Y., Little, S. 

Phrase: "Y.,"

Phrase: "Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: P., Mabry, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mabry,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.555: E., Miller, F. 

Phrase: "E.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.556: D., Ni, B., Nissen, J. 

Phrase: "D."

Phrase: ","

Phrase: "Ni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Nissen,"

Phrase: "J."
Processing 00000000.tx.557: S., Porter, W. 

Phrase: "S."

Phrase: ","

Phrase: "Porter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0402671:Porter [Professional or Occupational Group]
  1000   C2244327:porter [Molecular Function]

Phrase: "W."
Processing 00000000.tx.558: J., Potts, B. 

Phrase: "J.,"

Phrase: "Potts,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.559: D., Reel, J. 

Phrase: "D."

Phrase: ","

Phrase: "Reel,"

Phrase: "J."
Processing 00000000.tx.560: K., Stephenson, D., Su, Y., Shipley, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Stephenson,"

Phrase: "D."

Phrase: ","

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Shipley,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.561: A., Whitesitt, C. 

Phrase: "A.,"

Phrase: "Whitesitt,"

Phrase: "C."
Processing 00000000.tx.562: A., Yin, T., and Audia, J. 

Phrase: "A.,"

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Audia,"

Phrase: "J."
Processing 00000000.tx.563: E. 

Phrase: "E."
Processing 00000000.tx.564: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.565: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.566: 76, 173181[CrossRef][Medline] [OrderarticleviaInfotrieve] Brion, J. 

Phrase: "76,"

Phrase: "173181"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brion,"

Phrase: "J."
Processing 00000000.tx.567: P., Hanger, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hanger,"

Phrase: "D."
Processing 00000000.tx.568: P., Bruce, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332417:BRUCE [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: T., Couck, A. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Couck,"

Phrase: "A."
Processing 00000000.tx.570: M., Flament-Durand, J., and Anderton, B. 

Phrase: "M."

Phrase: ","

Phrase: "Flament-Durand,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.571: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.572: (1991) Biochem. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.573: J. 

Phrase: "J."
Processing 00000000.tx.574: 273, 127133[Medline] [OrderarticleviaInfotrieve] Essalmani, R., Macq, A. 

Phrase: "273,"

Phrase: "127133"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Essalmani,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Macq,"

Phrase: "A."
Processing 00000000.tx.575: F., Mercken, L., and Octave, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mercken,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Octave,"

Phrase: "J."
Processing 00000000.tx.576: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.577: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.578: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.579: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.580: Commun. 

Phrase: "Commun."
Processing 00000000.tx.581: 218, 8996[CrossRef][Medline] [OrderarticleviaInfotrieve] Macq, A. 

Phrase: "218,"

Phrase: "8996"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Macq,"

Phrase: "A."
Processing 00000000.tx.582: F., Czech, C., Essalmani, R., Brion, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Essalmani,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Brion,"

Phrase: "J."
Processing 00000000.tx.583: P., Maron, A., Mercken, L., Pradier, L., and Octave, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Maron,"

Phrase: "A.,"

Phrase: "Mercken,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Octave,"

Phrase: "J."
Processing 00000000.tx.584: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.585: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.586: Biol. 

Phrase: "Biol."
Processing 00000000.tx.587: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.588: 273, 2893128936[Abstract/Free FullText] Brewer, G. 

Phrase: "273,"

Phrase: "2893128936"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.589: J. 

Phrase: "J."
Processing 00000000.tx.590: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.591: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.592: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.593: 42, 674683[CrossRef][Medline] [OrderarticleviaInfotrieve] Lemarchand, P., Jaffe, H. 

Phrase: "42,"

Phrase: "674683"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lemarchand,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jaffe,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.594: A., Danel, C., Cid, M. 

Phrase: "A.,"

Phrase: "Danel,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707433:CID [Research Activity]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.595: C., Kleinman, H. 

Phrase: "C., Kleinman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.596: K., Stratford-Perricaudet, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Stratford-Perricaudet,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.597: D., Perricaudet, M., Pavirani, A., Lecocq, J. 

Phrase: "D."

Phrase: ","

Phrase: "Perricaudet,"

Phrase: "M."

Phrase: ","

Phrase: "Pavirani,"

Phrase: "A.,"

Phrase: "Lecocq,"

Phrase: "J."
Processing 00000000.tx.598: P., and Crystal, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Crystal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0427896:Crystal [Body Substance]
  1000   C0444626:Crystal [Chemical Viewed Structurally]
  1000   C1533132:Crystal [Body Substance]
  1000   C1704641:Crystal [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.599: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.600: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.601: Natl. 

Phrase: "Natl."
Processing 00000000.tx.602: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.603: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.604: U. 

Phrase: "U."
Processing 00000000.tx.605: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.606: A. 

Phrase: "A."
Processing 00000000.tx.607: 89, 64826486[Abstract/Free FullText] Stratford-Perricaudet, L. 

Phrase: "89,"

Phrase: "64826486"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stratford-Perricaudet,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.608: D., Makeh, I., Perricaudet, M., and Briand, P. 

Phrase: "D."

Phrase: ","

Phrase: "Makeh,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Perricaudet,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Briand,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.609: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.610: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.611: Investig. 

Phrase: "Investig."
Processing 00000000.tx.612: 90, 626630[Medline] [OrderarticleviaInfotrieve] Coghlan, M. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "626630"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Coghlan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.613: P., Culbert, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Culbert,"

Phrase: "A."
Processing 00000000.tx.614: A., Cross, D. 

Phrase: "A.,"

Phrase: "Cross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "D."
Processing 00000000.tx.615: A., Corcoran, S. 

Phrase: "A.,"

Phrase: "Corcoran,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.616: L., Yates, J. 

Phrase: "L., Yates,"

Phrase: "J."
Processing 00000000.tx.617: W., Pearce, N. 

Phrase: "W., Pearce,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.618: J., Rausch, O. 

Phrase: "J.,"

Phrase: "Rausch,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.619: L., Murphy, G. 

Phrase: "L., Murphy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.620: J., Carter, P. 

Phrase: "J.,"

Phrase: "Carter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.621: S., Roxbee, C. 

Phrase: "S."

Phrase: ","

Phrase: "Roxbee,"

Phrase: "C."
Processing 00000000.tx.622: L., Mills, D., Brown, M. 

Phrase: "L., Mills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599997:mills [Manufactured Object]

Phrase: "D."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.623: J., Haigh, D., Ward, R. 

Phrase: "J.,"

Phrase: "Haigh,"

Phrase: "D."

Phrase: ","

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.624: W., Smith, D. 

Phrase: "W., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.625: G., Murray, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murray,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.626: J., Reith, A. 

Phrase: "J.,"

Phrase: "Reith,"

Phrase: "A."
Processing 00000000.tx.627: D., and Holder, J. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Holder,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551377:holder [Manufactured Object]
  1000   C1555310:Holder [Idea or Concept]
  1000   C1706054:Holder [Medical Device]

Phrase: "J."
Processing 00000000.tx.628: C. 

Phrase: "C."
Processing 00000000.tx.629: (2000) Chem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.630: Biol. 

Phrase: "Biol."
Processing 00000000.tx.631: 7, 793803[CrossRef][Medline] [OrderarticleviaInfotrieve] Kienlen-Campard, P., and Octave, J. 

Phrase: "7,"

Phrase: "793803"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kienlen-Campard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Octave,"

Phrase: "J."
Processing 00000000.tx.632: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.633: (2002) Peptides (N. Y.) 

Phrase: "(2002"

Phrase: ")"

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(N. Y."

Phrase: ")"
Processing 00000000.tx.634: 23, 11991204[CrossRef] Ermolieff, J., Loy, J. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "11991204"

Phrase: "[CrossRef"

Phrase: "] Ermolieff,"

Phrase: "J.,"

Phrase: "Loy,"

Phrase: "J."
Processing 00000000.tx.635: A., Koelsch, G., and Tang, J. 

Phrase: "A.,"

Phrase: "Koelsch,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Tang,"

Phrase: "J."
Processing 00000000.tx.636: (2000) Biochemistry 39, 1245012456[CrossRef][Medline] [OrderarticleviaInfotrieve] Abbenante, G., Kovacs, D. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1245012456"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Abbenante,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.637: M., Leung, D. 

Phrase: "M."

Phrase: ","

Phrase: "Leung,"

Phrase: "D."
Processing 00000000.tx.638: L., Craik, D. 

Phrase: "L., Craik,"

Phrase: "D."
Processing 00000000.tx.639: J., Tanzi, R. 

Phrase: "J.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.640: E., and Fairlie, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Fairlie,"

Phrase: "D."
Processing 00000000.tx.641: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.642: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.643: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.644: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.645: Commun. 

Phrase: "Commun."
Processing 00000000.tx.646: 268, 133135[CrossRef][Medline] [OrderarticleviaInfotrieve] Kumaraswamy, S., Bergstedt, T., Shi, X., Rininsland, F., Kushon, S., Xia, W., Ley, K., Achyuthan, K., McBranch, D., and Whitten, D. 

Phrase: "268,"

Phrase: "133135"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kumaraswamy,"

Phrase: "S."

Phrase: ","

Phrase: "Bergstedt,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shi,"

Phrase: "X.,"

Phrase: "Rininsland,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kushon,"

Phrase: "S."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Ley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Achyuthan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "McBranch,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Whitten,"

Phrase: "D."
Processing 00000000.tx.647: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.648: Natl. 

Phrase: "Natl."
Processing 00000000.tx.649: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.650: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.651: U. 

Phrase: "U."
Processing 00000000.tx.652: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.653: A. 

Phrase: "A."
Processing 00000000.tx.654: 101, 75117515[Abstract/Free FullText] Leighton, F., Poole, B., Beaufay, H., Baudhuin, P., Coffey, J. 

Phrase: "101,"

Phrase: "75117515"

Phrase: "[Abstract/Free FullText"

Phrase: "] Leighton,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Poole,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Beaufay,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baudhuin,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Coffey,"

Phrase: "J."
Processing 00000000.tx.655: W., Fowler, S., and De Duve, C. 

Phrase: "W., Fowler,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "De Duve,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.656: (1968) J. 

Phrase: "(1968"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.657: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.658: 37, 482513[Abstract/Free FullText] Ida, N., Hartmann, T., Pantel, J., Schroder, J., Zerfass, R., Forstl, H., Sandbrink, R., Masters, C. 

Phrase: "37,"

Phrase: "482513"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hartmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pantel,"

Phrase: "J.,"

Phrase: "Schroder,"

Phrase: "J.,"

Phrase: "Zerfass,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Forstl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.659: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.660: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.661: Biol. 

Phrase: "Biol."
Processing 00000000.tx.662: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.663: 271, 2290822914[Abstract/Free FullText] Kienlen-Campard, P., Miolet, S., Tasiaux, B., and Octave, J. 

Phrase: "271,"

Phrase: "2290822914"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kienlen-Campard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Miolet,"

Phrase: "S."

Phrase: ","

Phrase: "Tasiaux,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Octave,"

Phrase: "J."
Processing 00000000.tx.664: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.665: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.666: Biol. 

Phrase: "Biol."
Processing 00000000.tx.667: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.668: 277, 1566615670[Abstract/Free FullText] Cupers, P., Veithen, A., Hoekstra, D., Baudhuin, P., and Courtoy, P. 

Phrase: "277,"

Phrase: "1566615670"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Veithen,"

Phrase: "A.,"

Phrase: "Hoekstra,"

Phrase: "D."

Phrase: ","

Phrase: "Baudhuin,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Courtoy,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.669: J. 

Phrase: "J."
Processing 00000000.tx.670: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.671: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.672: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.673: Commun. 

Phrase: "Commun."
Processing 00000000.tx.674: 236, 661664[CrossRef][Medline] [OrderarticleviaInfotrieve] Saraste, J., Palade, G. 

Phrase: "236,"

Phrase: "661664"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saraste,"

Phrase: "J.,"

Phrase: "Palade,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.675: E., and Farquhar, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Farquhar,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.676: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.677: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.678: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.679: 105, 20212029[Abstract] Citron, M., Teplow, D. 

Phrase: "105,"

Phrase: "20212029"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.680: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.681: J. 

Phrase: "J."
Processing 00000000.tx.682: (1995) Neuron 14, 661670[CrossRef][Medline] [OrderarticleviaInfotrieve] This Article Abstract Full Text (PDF) All Versions of this Article: 280/39/33220 most recent M501610200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Feyt, C. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "661670"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/39/33220 most recent M501610200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Feyt,"

Phrase: "C."
Processing 00000000.tx.683: Articles by Octave, J.-N. 

Phrase: "Articles by Octave,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J.-N."
Processing 00000000.tx.684: Articles citing this Article PubMed PubMed Citation Articles by Feyt, C. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Feyt,"

Phrase: "C."
Processing 00000000.tx.685: Articles by Octave, J.-N. 

Phrase: "Articles by Octave,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J.-N."
Processing 00000000.tx.686: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

